| 2.8 |
8.4 |
GO:0097402 |
neuroblast migration(GO:0097402) |
| 2.7 |
2.7 |
GO:0060067 |
cervix development(GO:0060067) |
| 2.4 |
7.1 |
GO:0060166 |
olfactory pit development(GO:0060166) |
| 2.1 |
10.5 |
GO:0070327 |
thyroid hormone transport(GO:0070327) |
| 2.1 |
6.2 |
GO:0035934 |
corticosterone secretion(GO:0035934) regulation of corticosterone secretion(GO:2000852) |
| 2.0 |
10.2 |
GO:0035262 |
gonad morphogenesis(GO:0035262) |
| 2.0 |
10.1 |
GO:0061642 |
chemoattraction of axon(GO:0061642) |
| 2.0 |
5.9 |
GO:0021759 |
globus pallidus development(GO:0021759) |
| 1.9 |
5.7 |
GO:1904274 |
tricellular tight junction assembly(GO:1904274) |
| 1.9 |
1.9 |
GO:0070366 |
regulation of hepatocyte differentiation(GO:0070366) |
| 1.8 |
3.6 |
GO:0072180 |
mesonephric duct development(GO:0072177) mesonephric duct morphogenesis(GO:0072180) |
| 1.7 |
5.2 |
GO:0021797 |
forebrain anterior/posterior pattern specification(GO:0021797) |
| 1.7 |
9.9 |
GO:0060024 |
rhythmic synaptic transmission(GO:0060024) |
| 1.6 |
4.9 |
GO:0072194 |
kidney smooth muscle tissue development(GO:0072194) |
| 1.6 |
4.8 |
GO:0016115 |
terpenoid catabolic process(GO:0016115) |
| 1.6 |
6.3 |
GO:0046552 |
eye photoreceptor cell fate commitment(GO:0042706) photoreceptor cell fate commitment(GO:0046552) |
| 1.6 |
1.6 |
GO:0018298 |
protein-chromophore linkage(GO:0018298) |
| 1.5 |
4.6 |
GO:0032696 |
negative regulation of interleukin-13 production(GO:0032696) |
| 1.5 |
7.5 |
GO:1900109 |
regulation of histone H3-K9 dimethylation(GO:1900109) |
| 1.5 |
4.4 |
GO:0070315 |
G1 to G0 transition involved in cell differentiation(GO:0070315) |
| 1.5 |
5.8 |
GO:0014846 |
esophagus smooth muscle contraction(GO:0014846) |
| 1.4 |
1.4 |
GO:1904672 |
regulation of somatic stem cell population maintenance(GO:1904672) |
| 1.4 |
4.2 |
GO:0060244 |
negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
| 1.4 |
5.6 |
GO:0033326 |
cerebrospinal fluid secretion(GO:0033326) |
| 1.4 |
4.2 |
GO:0060010 |
Sertoli cell fate commitment(GO:0060010) |
| 1.4 |
5.5 |
GO:0051902 |
negative regulation of mitochondrial depolarization(GO:0051902) negative regulation of membrane depolarization(GO:1904180) |
| 1.4 |
4.1 |
GO:0051892 |
negative regulation of cardioblast differentiation(GO:0051892) |
| 1.3 |
2.6 |
GO:0035880 |
embryonic nail plate morphogenesis(GO:0035880) |
| 1.3 |
3.8 |
GO:0060478 |
acrosomal vesicle exocytosis(GO:0060478) |
| 1.2 |
7.4 |
GO:0048318 |
axial mesoderm development(GO:0048318) |
| 1.2 |
4.9 |
GO:0006529 |
asparagine biosynthetic process(GO:0006529) |
| 1.2 |
4.9 |
GO:1900224 |
positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900224) positive regulation of mesoderm development(GO:2000382) |
| 1.2 |
3.6 |
GO:0003195 |
tricuspid valve formation(GO:0003195) |
| 1.2 |
2.4 |
GO:0038031 |
non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
| 1.2 |
1.2 |
GO:0045168 |
cell-cell signaling involved in cell fate commitment(GO:0045168) |
| 1.2 |
1.2 |
GO:0051490 |
negative regulation of filopodium assembly(GO:0051490) |
| 1.1 |
2.3 |
GO:0060167 |
regulation of adenosine receptor signaling pathway(GO:0060167) |
| 1.1 |
2.3 |
GO:2000744 |
anterior head development(GO:0097065) regulation of anterior head development(GO:2000742) positive regulation of anterior head development(GO:2000744) |
| 1.1 |
5.7 |
GO:1903609 |
angiotensin-activated signaling pathway involved in heart process(GO:0086098) negative regulation of peptidyl-tyrosine autophosphorylation(GO:1900085) negative regulation of inward rectifier potassium channel activity(GO:1903609) |
| 1.1 |
3.4 |
GO:0097374 |
sensory neuron axon guidance(GO:0097374) |
| 1.1 |
4.5 |
GO:1904936 |
cerebral cortex GABAergic interneuron migration(GO:0021853) interneuron migration(GO:1904936) |
| 1.1 |
4.5 |
GO:0007354 |
zygotic determination of anterior/posterior axis, embryo(GO:0007354) |
| 1.1 |
7.9 |
GO:2001199 |
negative regulation of dendritic cell differentiation(GO:2001199) |
| 1.1 |
1.1 |
GO:1901979 |
regulation of inward rectifier potassium channel activity(GO:1901979) |
| 1.1 |
6.4 |
GO:0048105 |
establishment of body hair or bristle planar orientation(GO:0048104) establishment of body hair planar orientation(GO:0048105) |
| 1.0 |
3.1 |
GO:0030200 |
heparan sulfate proteoglycan catabolic process(GO:0030200) |
| 1.0 |
2.0 |
GO:1904020 |
regulation of G-protein coupled receptor internalization(GO:1904020) |
| 1.0 |
3.0 |
GO:1903225 |
negative regulation of endodermal cell differentiation(GO:1903225) |
| 1.0 |
2.0 |
GO:0033159 |
negative regulation of protein import into nucleus, translocation(GO:0033159) |
| 1.0 |
3.9 |
GO:1902869 |
regulation of amacrine cell differentiation(GO:1902869) |
| 1.0 |
2.9 |
GO:0090274 |
positive regulation of somatostatin secretion(GO:0090274) |
| 1.0 |
2.9 |
GO:0060598 |
dichotomous subdivision of terminal units involved in mammary gland duct morphogenesis(GO:0060598) |
| 1.0 |
3.9 |
GO:2000832 |
negative regulation of steroid hormone secretion(GO:2000832) |
| 1.0 |
2.9 |
GO:0051582 |
positive regulation of neurotransmitter uptake(GO:0051582) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
| 1.0 |
4.8 |
GO:0071205 |
protein localization to juxtaparanode region of axon(GO:0071205) |
| 1.0 |
3.8 |
GO:0070346 |
positive regulation of fat cell proliferation(GO:0070346) |
| 1.0 |
1.9 |
GO:0072106 |
regulation of ureteric bud formation(GO:0072106) positive regulation of ureteric bud formation(GO:0072107) |
| 0.9 |
0.9 |
GO:1901252 |
regulation of intracellular transport of viral material(GO:1901252) |
| 0.9 |
1.9 |
GO:0060737 |
prostate epithelial cord elongation(GO:0060523) prostate gland morphogenetic growth(GO:0060737) |
| 0.9 |
2.8 |
GO:0072204 |
cell-cell signaling involved in kidney development(GO:0060995) Wnt signaling pathway involved in kidney development(GO:0061289) canonical Wnt signaling pathway involved in metanephric kidney development(GO:0061290) cell-cell signaling involved in metanephros development(GO:0072204) |
| 0.9 |
6.4 |
GO:0035701 |
hematopoietic stem cell migration(GO:0035701) |
| 0.9 |
2.7 |
GO:0019405 |
alditol catabolic process(GO:0019405) |
| 0.9 |
1.8 |
GO:0071336 |
regulation of hair follicle cell proliferation(GO:0071336) positive regulation of hair follicle cell proliferation(GO:0071338) |
| 0.9 |
3.6 |
GO:0072369 |
regulation of lipid transport by positive regulation of transcription from RNA polymerase II promoter(GO:0072369) |
| 0.9 |
0.9 |
GO:1900029 |
positive regulation of ruffle assembly(GO:1900029) |
| 0.9 |
0.9 |
GO:0016198 |
axon choice point recognition(GO:0016198) |
| 0.9 |
0.9 |
GO:1902187 |
negative regulation of viral release from host cell(GO:1902187) |
| 0.9 |
1.7 |
GO:0045603 |
positive regulation of endothelial cell differentiation(GO:0045603) |
| 0.9 |
7.8 |
GO:0042487 |
regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
| 0.9 |
0.9 |
GO:1901536 |
regulation of DNA demethylation(GO:1901535) negative regulation of DNA demethylation(GO:1901536) |
| 0.9 |
2.6 |
GO:0007223 |
Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
| 0.8 |
3.4 |
GO:0031133 |
regulation of axon diameter(GO:0031133) |
| 0.8 |
4.2 |
GO:0015705 |
iodide transport(GO:0015705) |
| 0.8 |
0.8 |
GO:0072076 |
nephrogenic mesenchyme development(GO:0072076) |
| 0.8 |
3.3 |
GO:0070125 |
mitochondrial translational elongation(GO:0070125) |
| 0.8 |
0.8 |
GO:0060994 |
regulation of transcription from RNA polymerase II promoter involved in kidney development(GO:0060994) |
| 0.8 |
2.5 |
GO:0032474 |
otolith morphogenesis(GO:0032474) |
| 0.8 |
2.5 |
GO:0051866 |
general adaptation syndrome(GO:0051866) |
| 0.8 |
3.3 |
GO:0035606 |
peptidyl-cysteine S-trans-nitrosylation(GO:0035606) |
| 0.8 |
4.9 |
GO:0072318 |
clathrin coat disassembly(GO:0072318) |
| 0.8 |
7.2 |
GO:1990845 |
adaptive thermogenesis(GO:1990845) |
| 0.8 |
2.4 |
GO:0003360 |
brainstem development(GO:0003360) |
| 0.8 |
1.6 |
GO:0072205 |
metanephric collecting duct development(GO:0072205) |
| 0.8 |
2.4 |
GO:0035585 |
calcium-mediated signaling using extracellular calcium source(GO:0035585) |
| 0.8 |
0.8 |
GO:1902938 |
regulation of intracellular calcium activated chloride channel activity(GO:1902938) |
| 0.8 |
5.5 |
GO:0060164 |
regulation of timing of neuron differentiation(GO:0060164) |
| 0.8 |
3.1 |
GO:0003199 |
endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) |
| 0.8 |
2.3 |
GO:0006226 |
dUMP biosynthetic process(GO:0006226) |
| 0.8 |
2.3 |
GO:0006097 |
glyoxylate cycle(GO:0006097) |
| 0.8 |
6.1 |
GO:0038028 |
insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
| 0.8 |
4.6 |
GO:0030916 |
otic vesicle formation(GO:0030916) |
| 0.8 |
2.3 |
GO:1903984 |
positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
| 0.8 |
3.0 |
GO:1904457 |
positive regulation of neuronal action potential(GO:1904457) |
| 0.8 |
3.8 |
GO:0040032 |
post-embryonic body morphogenesis(GO:0040032) |
| 0.8 |
4.5 |
GO:0070447 |
positive regulation of oligodendrocyte progenitor proliferation(GO:0070447) |
| 0.8 |
1.5 |
GO:0021913 |
regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification(GO:0021912) regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) |
| 0.8 |
2.3 |
GO:0014835 |
myoblast differentiation involved in skeletal muscle regeneration(GO:0014835) |
| 0.7 |
6.7 |
GO:0060371 |
regulation of atrial cardiac muscle cell membrane depolarization(GO:0060371) |
| 0.7 |
2.9 |
GO:0072185 |
canonical Wnt signaling pathway involved in positive regulation of wound healing(GO:0044330) lactic acid secretion(GO:0046722) metanephric cap development(GO:0072185) metanephric cap morphogenesis(GO:0072186) metanephric cap mesenchymal cell proliferation involved in metanephros development(GO:0090094) regulation of metanephric cap mesenchymal cell proliferation(GO:0090095) positive regulation of metanephric cap mesenchymal cell proliferation(GO:0090096) |
| 0.7 |
5.1 |
GO:0060666 |
dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
| 0.7 |
2.2 |
GO:1900738 |
positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
| 0.7 |
1.4 |
GO:0060849 |
regulation of transcription involved in lymphatic endothelial cell fate commitment(GO:0060849) |
| 0.7 |
1.4 |
GO:1903334 |
positive regulation of protein folding(GO:1903334) |
| 0.7 |
1.4 |
GO:0036518 |
chemorepulsion of dopaminergic neuron axon(GO:0036518) |
| 0.7 |
3.5 |
GO:0015871 |
choline transport(GO:0015871) |
| 0.7 |
2.1 |
GO:1903896 |
positive regulation of IRE1-mediated unfolded protein response(GO:1903896) |
| 0.7 |
1.4 |
GO:0072061 |
inner medullary collecting duct development(GO:0072061) |
| 0.7 |
2.8 |
GO:0070858 |
negative regulation of bile acid biosynthetic process(GO:0070858) negative regulation of bile acid metabolic process(GO:1904252) |
| 0.7 |
2.1 |
GO:0060913 |
cardiac cell fate determination(GO:0060913) |
| 0.7 |
2.1 |
GO:0030300 |
regulation of intestinal cholesterol absorption(GO:0030300) |
| 0.7 |
2.1 |
GO:0060392 |
negative regulation of SMAD protein import into nucleus(GO:0060392) |
| 0.7 |
0.7 |
GO:0098712 |
L-glutamate import across plasma membrane(GO:0098712) |
| 0.7 |
3.4 |
GO:2000325 |
regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
| 0.7 |
5.4 |
GO:0006477 |
protein sulfation(GO:0006477) |
| 0.7 |
2.7 |
GO:0060923 |
cardiac muscle cell fate commitment(GO:0060923) |
| 0.7 |
2.7 |
GO:2000138 |
positive regulation of cell proliferation involved in heart morphogenesis(GO:2000138) |
| 0.7 |
1.3 |
GO:0060242 |
contact inhibition(GO:0060242) |
| 0.7 |
5.3 |
GO:0016576 |
histone dephosphorylation(GO:0016576) |
| 0.7 |
1.3 |
GO:0000255 |
allantoin metabolic process(GO:0000255) |
| 0.7 |
3.3 |
GO:0060684 |
epithelial-mesenchymal cell signaling(GO:0060684) |
| 0.7 |
2.6 |
GO:2000383 |
regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
| 0.7 |
0.7 |
GO:0060066 |
oviduct development(GO:0060066) |
| 0.7 |
3.3 |
GO:1902683 |
regulation of receptor localization to synapse(GO:1902683) |
| 0.7 |
1.3 |
GO:0030240 |
skeletal muscle thin filament assembly(GO:0030240) |
| 0.7 |
0.7 |
GO:0014028 |
notochord formation(GO:0014028) |
| 0.7 |
4.6 |
GO:0060501 |
positive regulation of epithelial cell proliferation involved in lung morphogenesis(GO:0060501) |
| 0.7 |
0.7 |
GO:2000054 |
negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000054) |
| 0.6 |
6.5 |
GO:0042403 |
thyroid hormone metabolic process(GO:0042403) |
| 0.6 |
3.2 |
GO:0043314 |
negative regulation of neutrophil degranulation(GO:0043314) negative regulation of blood vessel remodeling(GO:0060313) |
| 0.6 |
2.6 |
GO:0006680 |
glucosylceramide catabolic process(GO:0006680) |
| 0.6 |
3.2 |
GO:0045918 |
negative regulation of cytolysis(GO:0045918) |
| 0.6 |
1.9 |
GO:0019659 |
fermentation(GO:0006113) glucose catabolic process to lactate(GO:0019659) glycolytic fermentation(GO:0019660) glucose catabolic process to lactate via pyruvate(GO:0019661) |
| 0.6 |
1.9 |
GO:0019255 |
glucose 1-phosphate metabolic process(GO:0019255) |
| 0.6 |
2.5 |
GO:0002924 |
negative regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002924) |
| 0.6 |
2.5 |
GO:0030091 |
protein repair(GO:0030091) |
| 0.6 |
1.9 |
GO:2000812 |
regulation of barbed-end actin filament capping(GO:2000812) |
| 0.6 |
3.1 |
GO:0006564 |
L-serine biosynthetic process(GO:0006564) |
| 0.6 |
5.0 |
GO:0033564 |
anterior/posterior axon guidance(GO:0033564) |
| 0.6 |
4.3 |
GO:1990416 |
cellular response to brain-derived neurotrophic factor stimulus(GO:1990416) |
| 0.6 |
3.7 |
GO:0036438 |
maintenance of lens transparency(GO:0036438) |
| 0.6 |
1.8 |
GO:1903048 |
regulation of acetylcholine-gated cation channel activity(GO:1903048) |
| 0.6 |
9.7 |
GO:0038092 |
nodal signaling pathway(GO:0038092) |
| 0.6 |
1.2 |
GO:1990523 |
bone regeneration(GO:1990523) |
| 0.6 |
0.6 |
GO:0021847 |
ventricular zone neuroblast division(GO:0021847) |
| 0.6 |
1.8 |
GO:0051940 |
regulation of dopamine uptake involved in synaptic transmission(GO:0051584) regulation of catecholamine uptake involved in synaptic transmission(GO:0051940) |
| 0.6 |
1.8 |
GO:1990046 |
positive regulation of mitochondrial DNA replication(GO:0090297) regulation of cardiolipin metabolic process(GO:1900208) positive regulation of cardiolipin metabolic process(GO:1900210) stress-induced mitochondrial fusion(GO:1990046) |
| 0.6 |
1.8 |
GO:0015772 |
disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
| 0.6 |
1.8 |
GO:0001830 |
trophectodermal cell fate commitment(GO:0001830) |
| 0.6 |
1.8 |
GO:0060385 |
axonogenesis involved in innervation(GO:0060385) |
| 0.6 |
0.6 |
GO:0032272 |
negative regulation of protein polymerization(GO:0032272) |
| 0.6 |
0.6 |
GO:0060214 |
endocardium formation(GO:0060214) |
| 0.6 |
1.2 |
GO:1901475 |
pyruvate transmembrane transport(GO:1901475) |
| 0.6 |
1.8 |
GO:0002191 |
cap-dependent translational initiation(GO:0002191) |
| 0.6 |
1.2 |
GO:0009826 |
unidimensional cell growth(GO:0009826) |
| 0.6 |
1.2 |
GO:0001787 |
natural killer cell proliferation(GO:0001787) |
| 0.6 |
3.6 |
GO:0035873 |
lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
| 0.6 |
3.0 |
GO:0031645 |
negative regulation of neurological system process(GO:0031645) |
| 0.6 |
5.3 |
GO:0019800 |
peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
| 0.6 |
1.8 |
GO:0006931 |
substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
| 0.6 |
2.4 |
GO:0002337 |
B-1a B cell differentiation(GO:0002337) |
| 0.6 |
4.1 |
GO:1905214 |
regulation of RNA binding(GO:1905214) |
| 0.6 |
0.6 |
GO:0046022 |
regulation of transcription from RNA polymerase II promoter, mitotic(GO:0046021) positive regulation of transcription from RNA polymerase II promoter during mitosis(GO:0046022) |
| 0.6 |
2.9 |
GO:0014886 |
transition between slow and fast fiber(GO:0014886) |
| 0.6 |
2.9 |
GO:0015960 |
diadenosine polyphosphate biosynthetic process(GO:0015960) diadenosine tetraphosphate metabolic process(GO:0015965) diadenosine tetraphosphate biosynthetic process(GO:0015966) |
| 0.6 |
2.9 |
GO:0003253 |
cardiac neural crest cell migration involved in outflow tract morphogenesis(GO:0003253) |
| 0.6 |
5.2 |
GO:1900121 |
negative regulation of receptor binding(GO:1900121) |
| 0.6 |
5.2 |
GO:0098700 |
neurotransmitter loading into synaptic vesicle(GO:0098700) |
| 0.6 |
0.6 |
GO:0031342 |
negative regulation of cell killing(GO:0031342) |
| 0.6 |
1.7 |
GO:0007621 |
negative regulation of female receptivity(GO:0007621) |
| 0.6 |
0.6 |
GO:0046878 |
regulation of saliva secretion(GO:0046877) positive regulation of saliva secretion(GO:0046878) |
| 0.6 |
6.3 |
GO:1990173 |
protein localization to nuclear body(GO:1903405) protein localization to Cajal body(GO:1904867) regulation of protein localization to Cajal body(GO:1904869) positive regulation of protein localization to Cajal body(GO:1904871) protein localization to nucleoplasm(GO:1990173) |
| 0.6 |
2.9 |
GO:1903553 |
positive regulation of extracellular exosome assembly(GO:1903553) |
| 0.6 |
5.7 |
GO:0070472 |
regulation of uterine smooth muscle contraction(GO:0070472) |
| 0.6 |
4.0 |
GO:0036072 |
intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
| 0.6 |
1.7 |
GO:1903538 |
meiotic cell cycle process involved in oocyte maturation(GO:1903537) regulation of meiotic cell cycle process involved in oocyte maturation(GO:1903538) |
| 0.6 |
1.7 |
GO:0046341 |
CDP-diacylglycerol metabolic process(GO:0046341) |
| 0.6 |
3.4 |
GO:0031034 |
myosin filament assembly(GO:0031034) |
| 0.6 |
1.7 |
GO:0001705 |
ectoderm formation(GO:0001705) |
| 0.6 |
1.7 |
GO:0015938 |
coenzyme A catabolic process(GO:0015938) nucleoside bisphosphate catabolic process(GO:0033869) ribonucleoside bisphosphate catabolic process(GO:0034031) purine nucleoside bisphosphate catabolic process(GO:0034034) |
| 0.6 |
2.2 |
GO:1903715 |
regulation of aerobic respiration(GO:1903715) |
| 0.6 |
0.6 |
GO:0071107 |
response to parathyroid hormone(GO:0071107) |
| 0.6 |
1.7 |
GO:0072734 |
response to staurosporine(GO:0072733) cellular response to staurosporine(GO:0072734) |
| 0.6 |
1.7 |
GO:0006546 |
glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
| 0.6 |
0.6 |
GO:0006999 |
nuclear pore organization(GO:0006999) |
| 0.6 |
1.7 |
GO:0006121 |
mitochondrial electron transport, succinate to ubiquinone(GO:0006121) |
| 0.6 |
1.7 |
GO:0040010 |
positive regulation of growth rate(GO:0040010) |
| 0.6 |
0.6 |
GO:0051305 |
chromosome movement towards spindle pole(GO:0051305) |
| 0.6 |
3.3 |
GO:0035331 |
negative regulation of hippo signaling(GO:0035331) |
| 0.5 |
2.2 |
GO:2000484 |
positive regulation of interleukin-8 secretion(GO:2000484) |
| 0.5 |
1.6 |
GO:1902219 |
negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
| 0.5 |
0.5 |
GO:0036118 |
hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
| 0.5 |
1.6 |
GO:0060672 |
epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
| 0.5 |
0.5 |
GO:0030214 |
hyaluronan catabolic process(GO:0030214) |
| 0.5 |
1.6 |
GO:0002538 |
arachidonic acid metabolite production involved in inflammatory response(GO:0002538) |
| 0.5 |
2.2 |
GO:0090282 |
positive regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071931) positive regulation of transcription involved in G2/M transition of mitotic cell cycle(GO:0090282) |
| 0.5 |
0.5 |
GO:0010637 |
negative regulation of mitochondrial fusion(GO:0010637) |
| 0.5 |
1.6 |
GO:1902162 |
regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902162) |
| 0.5 |
2.1 |
GO:0032229 |
negative regulation of synaptic transmission, GABAergic(GO:0032229) |
| 0.5 |
2.7 |
GO:0018002 |
N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
| 0.5 |
1.6 |
GO:0051030 |
snRNA transport(GO:0051030) |
| 0.5 |
0.5 |
GO:0090494 |
catecholamine uptake(GO:0090493) dopamine uptake(GO:0090494) |
| 0.5 |
1.1 |
GO:0002725 |
negative regulation of T cell cytokine production(GO:0002725) |
| 0.5 |
0.5 |
GO:0008626 |
granzyme-mediated apoptotic signaling pathway(GO:0008626) |
| 0.5 |
0.5 |
GO:0035728 |
response to hepatocyte growth factor(GO:0035728) |
| 0.5 |
1.6 |
GO:2000768 |
positive regulation of epithelial cell differentiation involved in kidney development(GO:2000698) positive regulation of nephron tubule epithelial cell differentiation(GO:2000768) |
| 0.5 |
0.5 |
GO:0003347 |
epicardial cell to mesenchymal cell transition(GO:0003347) |
| 0.5 |
2.6 |
GO:0030854 |
positive regulation of granulocyte differentiation(GO:0030854) |
| 0.5 |
3.1 |
GO:0031536 |
positive regulation of exit from mitosis(GO:0031536) |
| 0.5 |
3.1 |
GO:0098734 |
protein depalmitoylation(GO:0002084) macromolecule depalmitoylation(GO:0098734) |
| 0.5 |
1.6 |
GO:0030070 |
insulin processing(GO:0030070) |
| 0.5 |
4.7 |
GO:1900262 |
regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
| 0.5 |
2.1 |
GO:0018343 |
protein farnesylation(GO:0018343) |
| 0.5 |
1.0 |
GO:0033092 |
positive regulation of immature T cell proliferation in thymus(GO:0033092) |
| 0.5 |
1.6 |
GO:0072257 |
metanephric nephron tubule epithelial cell differentiation(GO:0072257) regulation of metanephric nephron tubule epithelial cell differentiation(GO:0072307) |
| 0.5 |
0.5 |
GO:1902338 |
negative regulation of apoptotic process involved in morphogenesis(GO:1902338) negative regulation of apoptotic process involved in development(GO:1904746) |
| 0.5 |
1.0 |
GO:1901896 |
positive regulation of calcium-transporting ATPase activity(GO:1901896) |
| 0.5 |
2.6 |
GO:1901097 |
negative regulation of autophagosome maturation(GO:1901097) |
| 0.5 |
2.6 |
GO:1900747 |
negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) |
| 0.5 |
0.5 |
GO:0035799 |
ureter maturation(GO:0035799) |
| 0.5 |
6.2 |
GO:0000244 |
spliceosomal tri-snRNP complex assembly(GO:0000244) |
| 0.5 |
0.5 |
GO:0032650 |
regulation of interleukin-1 alpha production(GO:0032650) positive regulation of interleukin-1 alpha production(GO:0032730) |
| 0.5 |
1.5 |
GO:0009153 |
purine deoxyribonucleotide biosynthetic process(GO:0009153) |
| 0.5 |
0.5 |
GO:0033563 |
dorsal/ventral axon guidance(GO:0033563) |
| 0.5 |
2.0 |
GO:0071787 |
endoplasmic reticulum tubular network assembly(GO:0071787) |
| 0.5 |
0.5 |
GO:0021586 |
pons maturation(GO:0021586) |
| 0.5 |
2.0 |
GO:0072513 |
positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
| 0.5 |
2.0 |
GO:1905063 |
regulation of vascular smooth muscle cell differentiation(GO:1905063) |
| 0.5 |
0.5 |
GO:0071166 |
ribonucleoprotein complex localization(GO:0071166) ribonucleoprotein complex export from nucleus(GO:0071426) |
| 0.5 |
0.5 |
GO:0033128 |
negative regulation of histone phosphorylation(GO:0033128) |
| 0.5 |
0.5 |
GO:0090135 |
actin filament branching(GO:0090135) |
| 0.5 |
3.5 |
GO:2000124 |
regulation of endocannabinoid signaling pathway(GO:2000124) |
| 0.5 |
3.5 |
GO:0033089 |
positive regulation of T cell differentiation in thymus(GO:0033089) positive regulation of thymocyte aggregation(GO:2000400) |
| 0.5 |
1.0 |
GO:2000510 |
positive regulation of dendritic cell chemotaxis(GO:2000510) |
| 0.5 |
1.5 |
GO:0043323 |
positive regulation of natural killer cell degranulation(GO:0043323) |
| 0.5 |
1.5 |
GO:0071707 |
immunoglobulin heavy chain V-D-J recombination(GO:0071707) |
| 0.5 |
0.5 |
GO:0003150 |
muscular septum morphogenesis(GO:0003150) |
| 0.5 |
0.5 |
GO:0060558 |
regulation of calcidiol 1-monooxygenase activity(GO:0060558) |
| 0.5 |
3.4 |
GO:0060272 |
embryonic skeletal joint morphogenesis(GO:0060272) |
| 0.5 |
3.0 |
GO:0006452 |
translational frameshifting(GO:0006452) positive regulation of translational termination(GO:0045905) |
| 0.5 |
8.8 |
GO:0021516 |
dorsal spinal cord development(GO:0021516) |
| 0.5 |
0.5 |
GO:0032241 |
positive regulation of nucleobase-containing compound transport(GO:0032241) |
| 0.5 |
5.8 |
GO:0030213 |
hyaluronan biosynthetic process(GO:0030213) |
| 0.5 |
1.0 |
GO:0007412 |
axon target recognition(GO:0007412) |
| 0.5 |
2.4 |
GO:0006177 |
GMP biosynthetic process(GO:0006177) |
| 0.5 |
1.9 |
GO:0051388 |
positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
| 0.5 |
1.5 |
GO:0032914 |
positive regulation of transforming growth factor beta1 production(GO:0032914) |
| 0.5 |
5.3 |
GO:2000580 |
positive regulation of microtubule motor activity(GO:2000576) regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000580) positive regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000582) |
| 0.5 |
0.5 |
GO:0034242 |
negative regulation of syncytium formation by plasma membrane fusion(GO:0034242) |
| 0.5 |
3.9 |
GO:0031665 |
negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
| 0.5 |
2.9 |
GO:0032439 |
endosome localization(GO:0032439) |
| 0.5 |
0.5 |
GO:0002901 |
mature B cell apoptotic process(GO:0002901) regulation of mature B cell apoptotic process(GO:0002905) negative regulation of mature B cell apoptotic process(GO:0002906) |
| 0.5 |
1.9 |
GO:1902340 |
telomeric heterochromatin assembly(GO:0031509) negative regulation of chromosome condensation(GO:1902340) |
| 0.5 |
1.4 |
GO:0060741 |
prostate gland stromal morphogenesis(GO:0060741) |
| 0.5 |
1.9 |
GO:0046294 |
formaldehyde catabolic process(GO:0046294) |
| 0.5 |
2.4 |
GO:0006189 |
'de novo' IMP biosynthetic process(GO:0006189) |
| 0.5 |
1.9 |
GO:0007113 |
endomitotic cell cycle(GO:0007113) |
| 0.5 |
3.3 |
GO:0070458 |
detoxification of nitrogen compound(GO:0051410) cellular detoxification of nitrogen compound(GO:0070458) |
| 0.5 |
3.8 |
GO:1904948 |
midbrain dopaminergic neuron differentiation(GO:1904948) |
| 0.5 |
2.8 |
GO:0002317 |
plasma cell differentiation(GO:0002317) |
| 0.5 |
0.5 |
GO:1990086 |
lens fiber cell apoptotic process(GO:1990086) |
| 0.5 |
0.5 |
GO:0030167 |
proteoglycan catabolic process(GO:0030167) |
| 0.5 |
0.9 |
GO:0019081 |
viral translation(GO:0019081) |
| 0.5 |
0.5 |
GO:0046364 |
hexose biosynthetic process(GO:0019319) monosaccharide biosynthetic process(GO:0046364) |
| 0.5 |
1.4 |
GO:0097350 |
neutrophil clearance(GO:0097350) |
| 0.5 |
0.5 |
GO:0060003 |
copper ion export(GO:0060003) |
| 0.5 |
1.4 |
GO:2000501 |
natural killer cell chemotaxis(GO:0035747) regulation of natural killer cell chemotaxis(GO:2000501) |
| 0.5 |
3.3 |
GO:0008343 |
adult feeding behavior(GO:0008343) |
| 0.5 |
2.3 |
GO:0044351 |
macropinocytosis(GO:0044351) |
| 0.5 |
0.5 |
GO:0061762 |
CAMKK-AMPK signaling cascade(GO:0061762) |
| 0.5 |
2.3 |
GO:0046864 |
retinol transport(GO:0034633) isoprenoid transport(GO:0046864) terpenoid transport(GO:0046865) alveolar primary septum development(GO:0061143) |
| 0.5 |
0.9 |
GO:0090365 |
regulation of mRNA modification(GO:0090365) |
| 0.5 |
0.5 |
GO:0035963 |
response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
| 0.5 |
1.4 |
GO:0072717 |
cellular response to actinomycin D(GO:0072717) |
| 0.5 |
1.4 |
GO:0018125 |
peptidyl-cysteine methylation(GO:0018125) |
| 0.5 |
1.4 |
GO:0045819 |
plasmacytoid dendritic cell activation(GO:0002270) positive regulation of glycogen catabolic process(GO:0045819) |
| 0.5 |
2.8 |
GO:0032796 |
uropod organization(GO:0032796) |
| 0.5 |
4.1 |
GO:0033601 |
positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
| 0.5 |
4.6 |
GO:0090394 |
negative regulation of excitatory postsynaptic potential(GO:0090394) |
| 0.5 |
1.4 |
GO:0043686 |
co-translational protein modification(GO:0043686) |
| 0.5 |
4.1 |
GO:0046643 |
regulation of gamma-delta T cell differentiation(GO:0045586) regulation of gamma-delta T cell activation(GO:0046643) |
| 0.5 |
0.5 |
GO:0009204 |
deoxyribonucleoside triphosphate catabolic process(GO:0009204) |
| 0.5 |
3.2 |
GO:0098909 |
regulation of cardiac muscle cell action potential involved in regulation of contraction(GO:0098909) |
| 0.5 |
1.8 |
GO:1904565 |
response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904565) cellular response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904566) |
| 0.5 |
1.4 |
GO:2001286 |
regulation of caveolin-mediated endocytosis(GO:2001286) |
| 0.5 |
4.1 |
GO:0048251 |
elastic fiber assembly(GO:0048251) |
| 0.5 |
1.4 |
GO:0072217 |
negative regulation of metanephros development(GO:0072217) |
| 0.5 |
1.4 |
GO:0033122 |
regulation of purine nucleotide catabolic process(GO:0033121) negative regulation of purine nucleotide catabolic process(GO:0033122) |
| 0.5 |
0.9 |
GO:0035089 |
establishment of apical/basal cell polarity(GO:0035089) |
| 0.5 |
5.4 |
GO:0006012 |
galactose metabolic process(GO:0006012) |
| 0.5 |
2.3 |
GO:0090170 |
regulation of Golgi inheritance(GO:0090170) |
| 0.5 |
1.4 |
GO:0030043 |
actin filament fragmentation(GO:0030043) |
| 0.4 |
0.4 |
GO:0006678 |
glucosylceramide metabolic process(GO:0006678) |
| 0.4 |
4.0 |
GO:0070236 |
negative regulation of activation-induced cell death of T cells(GO:0070236) |
| 0.4 |
0.4 |
GO:0090118 |
receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport(GO:0090118) |
| 0.4 |
0.4 |
GO:0030046 |
parallel actin filament bundle assembly(GO:0030046) |
| 0.4 |
0.4 |
GO:0033088 |
negative regulation of immature T cell proliferation in thymus(GO:0033088) |
| 0.4 |
0.9 |
GO:0071603 |
endothelial cell-cell adhesion(GO:0071603) |
| 0.4 |
2.2 |
GO:0035795 |
negative regulation of mitochondrial membrane permeability(GO:0035795) |
| 0.4 |
0.4 |
GO:0051571 |
positive regulation of histone H3-K4 methylation(GO:0051571) |
| 0.4 |
3.1 |
GO:1990504 |
dense core granule exocytosis(GO:1990504) |
| 0.4 |
0.4 |
GO:0050862 |
positive regulation of T cell receptor signaling pathway(GO:0050862) |
| 0.4 |
1.3 |
GO:0070634 |
transepithelial ammonium transport(GO:0070634) |
| 0.4 |
1.3 |
GO:0044313 |
protein K6-linked deubiquitination(GO:0044313) |
| 0.4 |
0.4 |
GO:1902455 |
negative regulation of stem cell population maintenance(GO:1902455) |
| 0.4 |
5.7 |
GO:0033211 |
adiponectin-activated signaling pathway(GO:0033211) |
| 0.4 |
2.2 |
GO:1902255 |
positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902255) |
| 0.4 |
2.2 |
GO:0051012 |
microtubule sliding(GO:0051012) |
| 0.4 |
1.3 |
GO:0015747 |
urate transport(GO:0015747) |
| 0.4 |
3.5 |
GO:0043951 |
negative regulation of cAMP-mediated signaling(GO:0043951) |
| 0.4 |
6.1 |
GO:0007213 |
G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) |
| 0.4 |
2.2 |
GO:0042364 |
water-soluble vitamin biosynthetic process(GO:0042364) |
| 0.4 |
1.3 |
GO:0035878 |
nail development(GO:0035878) |
| 0.4 |
1.3 |
GO:0010248 |
B cell negative selection(GO:0002352) establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
| 0.4 |
1.3 |
GO:1904046 |
negative regulation of vascular endothelial growth factor production(GO:1904046) |
| 0.4 |
1.7 |
GO:0031580 |
membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
| 0.4 |
4.3 |
GO:0042989 |
sequestering of actin monomers(GO:0042989) |
| 0.4 |
0.9 |
GO:0032713 |
negative regulation of interleukin-4 production(GO:0032713) |
| 0.4 |
3.0 |
GO:0032511 |
late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) |
| 0.4 |
1.3 |
GO:0006106 |
fumarate metabolic process(GO:0006106) |
| 0.4 |
3.4 |
GO:0002118 |
aggressive behavior(GO:0002118) |
| 0.4 |
0.9 |
GO:0003032 |
detection of oxygen(GO:0003032) |
| 0.4 |
1.7 |
GO:0010890 |
positive regulation of sequestering of triglyceride(GO:0010890) |
| 0.4 |
0.4 |
GO:0045575 |
basophil activation involved in immune response(GO:0002276) basophil activation(GO:0045575) |
| 0.4 |
0.4 |
GO:0032472 |
Golgi calcium ion transport(GO:0032472) |
| 0.4 |
1.7 |
GO:0030576 |
Cajal body organization(GO:0030576) |
| 0.4 |
0.8 |
GO:0010838 |
positive regulation of keratinocyte proliferation(GO:0010838) |
| 0.4 |
0.8 |
GO:0006655 |
phosphatidylglycerol biosynthetic process(GO:0006655) cardiolipin biosynthetic process(GO:0032049) |
| 0.4 |
2.5 |
GO:0045218 |
zonula adherens maintenance(GO:0045218) |
| 0.4 |
0.4 |
GO:0048631 |
skeletal muscle tissue growth(GO:0048630) regulation of skeletal muscle tissue growth(GO:0048631) |
| 0.4 |
2.5 |
GO:0007021 |
tubulin complex assembly(GO:0007021) |
| 0.4 |
2.9 |
GO:0006105 |
succinate metabolic process(GO:0006105) |
| 0.4 |
0.4 |
GO:1900034 |
regulation of cellular response to heat(GO:1900034) |
| 0.4 |
1.7 |
GO:2001271 |
negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
| 0.4 |
0.8 |
GO:1901731 |
positive regulation of platelet aggregation(GO:1901731) |
| 0.4 |
2.9 |
GO:0009249 |
protein lipoylation(GO:0009249) |
| 0.4 |
0.8 |
GO:0043321 |
regulation of natural killer cell degranulation(GO:0043321) |
| 0.4 |
1.2 |
GO:0046654 |
tetrahydrofolate biosynthetic process(GO:0046654) |
| 0.4 |
1.7 |
GO:0015786 |
UDP-glucose transport(GO:0015786) |
| 0.4 |
0.4 |
GO:0033140 |
negative regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033140) |
| 0.4 |
0.8 |
GO:0046685 |
response to arsenic-containing substance(GO:0046685) |
| 0.4 |
1.6 |
GO:0060265 |
positive regulation of respiratory burst involved in inflammatory response(GO:0060265) |
| 0.4 |
2.9 |
GO:0003433 |
chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
| 0.4 |
0.8 |
GO:0090187 |
positive regulation of pancreatic juice secretion(GO:0090187) |
| 0.4 |
0.8 |
GO:1902414 |
protein localization to cell junction(GO:1902414) |
| 0.4 |
0.4 |
GO:1904959 |
regulation of electron carrier activity(GO:1904732) regulation of cytochrome-c oxidase activity(GO:1904959) |
| 0.4 |
2.8 |
GO:0006621 |
protein retention in ER lumen(GO:0006621) |
| 0.4 |
0.8 |
GO:0006507 |
GPI anchor release(GO:0006507) |
| 0.4 |
2.4 |
GO:0010992 |
ubiquitin homeostasis(GO:0010992) |
| 0.4 |
1.2 |
GO:0031660 |
regulation of cyclin-dependent protein serine/threonine kinase activity involved in G2/M transition of mitotic cell cycle(GO:0031660) positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G2/M transition of mitotic cell cycle(GO:0031662) |
| 0.4 |
1.6 |
GO:0035927 |
RNA import into mitochondrion(GO:0035927) |
| 0.4 |
8.0 |
GO:0045116 |
protein neddylation(GO:0045116) |
| 0.4 |
2.0 |
GO:0006207 |
'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) |
| 0.4 |
0.4 |
GO:0045628 |
regulation of T-helper 2 cell differentiation(GO:0045628) |
| 0.4 |
0.8 |
GO:0042536 |
negative regulation of tumor necrosis factor biosynthetic process(GO:0042536) |
| 0.4 |
2.0 |
GO:0007253 |
cytoplasmic sequestering of NF-kappaB(GO:0007253) |
| 0.4 |
1.2 |
GO:0010958 |
regulation of amino acid import(GO:0010958) |
| 0.4 |
0.4 |
GO:0001778 |
plasma membrane repair(GO:0001778) |
| 0.4 |
2.4 |
GO:1903847 |
regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
| 0.4 |
2.0 |
GO:0000492 |
box C/D snoRNP assembly(GO:0000492) |
| 0.4 |
1.6 |
GO:0007386 |
compartment pattern specification(GO:0007386) |
| 0.4 |
6.4 |
GO:0070262 |
peptidyl-serine dephosphorylation(GO:0070262) |
| 0.4 |
2.4 |
GO:0035902 |
response to immobilization stress(GO:0035902) |
| 0.4 |
1.6 |
GO:0046726 |
positive regulation by virus of viral protein levels in host cell(GO:0046726) |
| 0.4 |
1.6 |
GO:0046543 |
development of secondary female sexual characteristics(GO:0046543) |
| 0.4 |
3.2 |
GO:0048170 |
positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
| 0.4 |
1.2 |
GO:0016132 |
brassinosteroid metabolic process(GO:0016131) brassinosteroid biosynthetic process(GO:0016132) |
| 0.4 |
2.4 |
GO:1903755 |
regulation of SUMO transferase activity(GO:1903182) positive regulation of SUMO transferase activity(GO:1903755) |
| 0.4 |
0.4 |
GO:0034310 |
primary alcohol catabolic process(GO:0034310) |
| 0.4 |
1.2 |
GO:0010533 |
regulation of activation of Janus kinase activity(GO:0010533) |
| 0.4 |
1.2 |
GO:1900740 |
regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
| 0.4 |
2.3 |
GO:0006616 |
SRP-dependent cotranslational protein targeting to membrane, translocation(GO:0006616) |
| 0.4 |
1.9 |
GO:0001842 |
neural fold formation(GO:0001842) |
| 0.4 |
1.9 |
GO:0015803 |
branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
| 0.4 |
0.4 |
GO:0046166 |
glyceraldehyde-3-phosphate biosynthetic process(GO:0046166) |
| 0.4 |
0.4 |
GO:0051665 |
membrane raft localization(GO:0051665) |
| 0.4 |
1.9 |
GO:1902031 |
regulation of NADP metabolic process(GO:1902031) |
| 0.4 |
1.2 |
GO:0098886 |
modification of dendritic spine(GO:0098886) |
| 0.4 |
1.2 |
GO:0002551 |
mast cell chemotaxis(GO:0002551) regulation of mast cell chemotaxis(GO:0060753) positive regulation of mast cell chemotaxis(GO:0060754) mast cell migration(GO:0097531) |
| 0.4 |
0.4 |
GO:0060160 |
negative regulation of dopamine receptor signaling pathway(GO:0060160) |
| 0.4 |
1.5 |
GO:0005981 |
regulation of glycogen catabolic process(GO:0005981) |
| 0.4 |
0.8 |
GO:0071550 |
death-inducing signaling complex assembly(GO:0071550) |
| 0.4 |
0.4 |
GO:0045110 |
intermediate filament bundle assembly(GO:0045110) |
| 0.4 |
0.4 |
GO:0006933 |
negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
| 0.4 |
1.1 |
GO:0016561 |
protein import into peroxisome matrix, translocation(GO:0016561) |
| 0.4 |
1.1 |
GO:2000373 |
regulation of DNA topoisomerase (ATP-hydrolyzing) activity(GO:2000371) positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity(GO:2000373) |
| 0.4 |
1.9 |
GO:0060340 |
positive regulation of type I interferon-mediated signaling pathway(GO:0060340) |
| 0.4 |
2.6 |
GO:0015670 |
carbon dioxide transport(GO:0015670) |
| 0.4 |
0.4 |
GO:0032461 |
positive regulation of protein oligomerization(GO:0032461) |
| 0.4 |
1.1 |
GO:0016540 |
protein autoprocessing(GO:0016540) |
| 0.4 |
2.6 |
GO:0097411 |
hypoxia-inducible factor-1alpha signaling pathway(GO:0097411) |
| 0.4 |
6.0 |
GO:0043248 |
proteasome assembly(GO:0043248) |
| 0.4 |
0.7 |
GO:0010692 |
regulation of alkaline phosphatase activity(GO:0010692) negative regulation of alkaline phosphatase activity(GO:0010693) |
| 0.4 |
2.2 |
GO:0019884 |
antigen processing and presentation of exogenous antigen(GO:0019884) |
| 0.4 |
1.5 |
GO:1904529 |
regulation of actin filament binding(GO:1904529) regulation of actin binding(GO:1904616) |
| 0.4 |
4.8 |
GO:0045647 |
negative regulation of erythrocyte differentiation(GO:0045647) |
| 0.4 |
1.9 |
GO:0060528 |
secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
| 0.4 |
0.4 |
GO:1902074 |
response to salt(GO:1902074) |
| 0.4 |
1.8 |
GO:0015669 |
gas transport(GO:0015669) |
| 0.4 |
4.0 |
GO:0034551 |
respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
| 0.4 |
0.7 |
GO:0045085 |
negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
| 0.4 |
0.7 |
GO:0044539 |
long-chain fatty acid import(GO:0044539) |
| 0.4 |
0.4 |
GO:1900748 |
positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
| 0.4 |
1.1 |
GO:0002184 |
cytoplasmic translational termination(GO:0002184) |
| 0.4 |
0.4 |
GO:0002043 |
blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
| 0.4 |
1.1 |
GO:0036090 |
cleavage furrow ingression(GO:0036090) |
| 0.4 |
4.0 |
GO:0015721 |
bile acid and bile salt transport(GO:0015721) |
| 0.4 |
1.4 |
GO:1901837 |
negative regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901837) |
| 0.4 |
4.0 |
GO:0051451 |
myoblast migration(GO:0051451) |
| 0.4 |
1.1 |
GO:0061588 |
calcium activated phospholipid scrambling(GO:0061588) calcium activated phosphatidylserine scrambling(GO:0061589) calcium activated phosphatidylcholine scrambling(GO:0061590) calcium activated galactosylceramide scrambling(GO:0061591) |
| 0.4 |
0.4 |
GO:0001781 |
neutrophil apoptotic process(GO:0001781) regulation of neutrophil apoptotic process(GO:0033029) positive regulation of myeloid cell apoptotic process(GO:0033034) |
| 0.4 |
0.7 |
GO:0071211 |
protein targeting to vacuole involved in autophagy(GO:0071211) |
| 0.4 |
0.4 |
GO:2000170 |
positive regulation of peptidyl-cysteine S-nitrosylation(GO:2000170) |
| 0.4 |
1.4 |
GO:0001692 |
histamine metabolic process(GO:0001692) |
| 0.4 |
2.5 |
GO:1903069 |
regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903069) |
| 0.4 |
0.7 |
GO:1904058 |
positive regulation of sensory perception of pain(GO:1904058) |
| 0.4 |
0.4 |
GO:0019262 |
N-acetylneuraminate catabolic process(GO:0019262) |
| 0.4 |
1.1 |
GO:0003105 |
negative regulation of glomerular filtration(GO:0003105) |
| 0.4 |
5.0 |
GO:0007220 |
Notch receptor processing(GO:0007220) |
| 0.4 |
0.4 |
GO:0019401 |
alditol biosynthetic process(GO:0019401) |
| 0.4 |
2.1 |
GO:0009146 |
purine nucleoside triphosphate catabolic process(GO:0009146) |
| 0.4 |
5.0 |
GO:0042744 |
hydrogen peroxide catabolic process(GO:0042744) |
| 0.4 |
2.1 |
GO:0045618 |
positive regulation of keratinocyte differentiation(GO:0045618) |
| 0.4 |
0.4 |
GO:0003219 |
cardiac right ventricle formation(GO:0003219) |
| 0.4 |
1.1 |
GO:0010804 |
negative regulation of tumor necrosis factor-mediated signaling pathway(GO:0010804) |
| 0.4 |
6.7 |
GO:0000028 |
ribosomal small subunit assembly(GO:0000028) |
| 0.4 |
0.7 |
GO:1901491 |
negative regulation of lymphangiogenesis(GO:1901491) |
| 0.4 |
0.7 |
GO:0001803 |
type III hypersensitivity(GO:0001802) regulation of type III hypersensitivity(GO:0001803) positive regulation of type III hypersensitivity(GO:0001805) |
| 0.4 |
0.4 |
GO:0019389 |
glucuronoside metabolic process(GO:0019389) |
| 0.4 |
1.1 |
GO:0002014 |
vasoconstriction of artery involved in ischemic response to lowering of systemic arterial blood pressure(GO:0002014) |
| 0.4 |
1.8 |
GO:0070345 |
negative regulation of fat cell proliferation(GO:0070345) |
| 0.3 |
1.0 |
GO:1901421 |
positive regulation of response to alcohol(GO:1901421) |
| 0.3 |
3.5 |
GO:0070940 |
dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
| 0.3 |
0.3 |
GO:0035022 |
positive regulation of Rac protein signal transduction(GO:0035022) |
| 0.3 |
2.1 |
GO:0090166 |
Golgi disassembly(GO:0090166) |
| 0.3 |
1.0 |
GO:0016554 |
cytidine to uridine editing(GO:0016554) |
| 0.3 |
7.3 |
GO:0032897 |
negative regulation of viral transcription(GO:0032897) |
| 0.3 |
0.7 |
GO:1904879 |
positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1904879) |
| 0.3 |
2.8 |
GO:0036344 |
platelet morphogenesis(GO:0036344) |
| 0.3 |
0.3 |
GO:1901187 |
regulation of ephrin receptor signaling pathway(GO:1901187) |
| 0.3 |
5.1 |
GO:0016486 |
peptide hormone processing(GO:0016486) |
| 0.3 |
1.0 |
GO:1904207 |
chemokine (C-C motif) ligand 2 secretion(GO:0035926) regulation of chemokine (C-C motif) ligand 2 secretion(GO:1904207) positive regulation of chemokine (C-C motif) ligand 2 secretion(GO:1904209) |
| 0.3 |
1.0 |
GO:0033762 |
response to glucagon(GO:0033762) |
| 0.3 |
4.1 |
GO:0000463 |
maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
| 0.3 |
10.2 |
GO:0070979 |
protein K11-linked ubiquitination(GO:0070979) |
| 0.3 |
1.4 |
GO:0046967 |
cytosol to ER transport(GO:0046967) |
| 0.3 |
0.7 |
GO:0002408 |
myeloid dendritic cell chemotaxis(GO:0002408) |
| 0.3 |
0.3 |
GO:0071169 |
establishment of protein localization to chromatin(GO:0071169) |
| 0.3 |
0.7 |
GO:0000973 |
posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000973) |
| 0.3 |
1.0 |
GO:0046952 |
ketone body catabolic process(GO:0046952) |
| 0.3 |
1.0 |
GO:0010796 |
regulation of multivesicular body size(GO:0010796) |
| 0.3 |
0.7 |
GO:1902302 |
regulation of potassium ion export(GO:1902302) |
| 0.3 |
0.7 |
GO:0075136 |
response to defenses of other organism involved in symbiotic interaction(GO:0052173) response to host defenses(GO:0052200) response to host(GO:0075136) |
| 0.3 |
3.4 |
GO:0045899 |
positive regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045899) |
| 0.3 |
0.3 |
GO:0042776 |
mitochondrial ATP synthesis coupled proton transport(GO:0042776) |
| 0.3 |
0.3 |
GO:0030321 |
transepithelial chloride transport(GO:0030321) |
| 0.3 |
2.0 |
GO:2000254 |
regulation of male germ cell proliferation(GO:2000254) |
| 0.3 |
1.7 |
GO:0045650 |
negative regulation of macrophage differentiation(GO:0045650) |
| 0.3 |
0.3 |
GO:0061668 |
mitochondrial ribosome assembly(GO:0061668) |
| 0.3 |
0.3 |
GO:1902730 |
positive regulation of proteoglycan biosynthetic process(GO:1902730) |
| 0.3 |
0.7 |
GO:0021539 |
subthalamus development(GO:0021539) |
| 0.3 |
1.0 |
GO:0071163 |
DNA replication preinitiation complex assembly(GO:0071163) |
| 0.3 |
1.3 |
GO:0035814 |
negative regulation of renal sodium excretion(GO:0035814) |
| 0.3 |
0.7 |
GO:0002035 |
brain renin-angiotensin system(GO:0002035) |
| 0.3 |
1.0 |
GO:1905051 |
regulation of base-excision repair(GO:1905051) positive regulation of base-excision repair(GO:1905053) |
| 0.3 |
0.3 |
GO:0071072 |
negative regulation of phospholipid biosynthetic process(GO:0071072) |
| 0.3 |
0.7 |
GO:0070488 |
neutrophil aggregation(GO:0070488) |
| 0.3 |
2.0 |
GO:0045217 |
cell-cell junction maintenance(GO:0045217) |
| 0.3 |
1.0 |
GO:1990859 |
cellular response to endothelin(GO:1990859) |
| 0.3 |
2.0 |
GO:0045198 |
establishment of epithelial cell apical/basal polarity(GO:0045198) |
| 0.3 |
1.0 |
GO:0034035 |
sulfate assimilation(GO:0000103) purine ribonucleoside bisphosphate metabolic process(GO:0034035) 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
| 0.3 |
1.3 |
GO:0042104 |
positive regulation of activated T cell proliferation(GO:0042104) |
| 0.3 |
3.9 |
GO:0070389 |
chaperone cofactor-dependent protein refolding(GO:0070389) |
| 0.3 |
0.3 |
GO:0001922 |
B-1 B cell homeostasis(GO:0001922) |
| 0.3 |
0.3 |
GO:0044339 |
canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
| 0.3 |
0.3 |
GO:0070318 |
positive regulation of G0 to G1 transition(GO:0070318) |
| 0.3 |
3.6 |
GO:0061302 |
smooth muscle cell-matrix adhesion(GO:0061302) |
| 0.3 |
3.9 |
GO:0002227 |
innate immune response in mucosa(GO:0002227) |
| 0.3 |
0.7 |
GO:0090273 |
regulation of somatostatin secretion(GO:0090273) |
| 0.3 |
0.7 |
GO:0071638 |
negative regulation of monocyte chemotactic protein-1 production(GO:0071638) |
| 0.3 |
0.6 |
GO:0032804 |
negative regulation of low-density lipoprotein particle receptor catabolic process(GO:0032804) negative regulation of receptor catabolic process(GO:2000645) |
| 0.3 |
1.6 |
GO:0061732 |
mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
| 0.3 |
0.3 |
GO:0021986 |
epithalamus development(GO:0021538) habenula development(GO:0021986) |
| 0.3 |
0.6 |
GO:2000774 |
positive regulation of cellular senescence(GO:2000774) |
| 0.3 |
1.6 |
GO:0098914 |
membrane repolarization during atrial cardiac muscle cell action potential(GO:0098914) |
| 0.3 |
0.3 |
GO:0010643 |
cell communication by chemical coupling(GO:0010643) |
| 0.3 |
1.0 |
GO:0045760 |
positive regulation of action potential(GO:0045760) |
| 0.3 |
2.6 |
GO:0035414 |
negative regulation of catenin import into nucleus(GO:0035414) |
| 0.3 |
0.3 |
GO:0014719 |
skeletal muscle satellite cell activation(GO:0014719) |
| 0.3 |
0.3 |
GO:0046471 |
cardiolipin metabolic process(GO:0032048) phosphatidylglycerol metabolic process(GO:0046471) |
| 0.3 |
2.6 |
GO:0070874 |
negative regulation of glycogen biosynthetic process(GO:0045719) negative regulation of glycogen metabolic process(GO:0070874) |
| 0.3 |
0.6 |
GO:0090071 |
negative regulation of ribosome biogenesis(GO:0090071) |
| 0.3 |
1.0 |
GO:0072014 |
proximal tubule development(GO:0072014) |
| 0.3 |
1.0 |
GO:0009051 |
pentose-phosphate shunt, oxidative branch(GO:0009051) |
| 0.3 |
0.6 |
GO:0072378 |
blood coagulation, fibrin clot formation(GO:0072378) |
| 0.3 |
0.6 |
GO:0048793 |
pronephros development(GO:0048793) |
| 0.3 |
3.8 |
GO:0006857 |
oligopeptide transport(GO:0006857) |
| 0.3 |
0.6 |
GO:0046122 |
purine deoxyribonucleoside metabolic process(GO:0046122) |
| 0.3 |
0.9 |
GO:2000312 |
regulation of kainate selective glutamate receptor activity(GO:2000312) |
| 0.3 |
0.3 |
GO:0097051 |
establishment of protein localization to endoplasmic reticulum membrane(GO:0097051) |
| 0.3 |
2.2 |
GO:0046015 |
regulation of transcription by glucose(GO:0046015) |
| 0.3 |
0.3 |
GO:1904809 |
dense core granule localization(GO:0032253) dense core granule transport(GO:1901950) regulation of dense core granule transport(GO:1904809) positive regulation of dense core granule transport(GO:1904811) |
| 0.3 |
1.9 |
GO:0016264 |
gap junction assembly(GO:0016264) |
| 0.3 |
0.3 |
GO:0006103 |
2-oxoglutarate metabolic process(GO:0006103) |
| 0.3 |
0.3 |
GO:0046013 |
T cell homeostatic proliferation(GO:0001777) regulation of T cell homeostatic proliferation(GO:0046013) |
| 0.3 |
0.6 |
GO:0007089 |
traversing start control point of mitotic cell cycle(GO:0007089) |
| 0.3 |
1.6 |
GO:1903378 |
positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903378) |
| 0.3 |
0.3 |
GO:0014063 |
negative regulation of serotonin secretion(GO:0014063) |
| 0.3 |
0.9 |
GO:0042822 |
pyridoxal phosphate metabolic process(GO:0042822) |
| 0.3 |
1.2 |
GO:0051006 |
positive regulation of lipoprotein lipase activity(GO:0051006) |
| 0.3 |
2.2 |
GO:0019673 |
GDP-mannose metabolic process(GO:0019673) |
| 0.3 |
0.3 |
GO:0070885 |
negative regulation of calcineurin-NFAT signaling cascade(GO:0070885) |
| 0.3 |
6.5 |
GO:0099517 |
anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
| 0.3 |
0.9 |
GO:1902235 |
regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902235) |
| 0.3 |
0.3 |
GO:2000643 |
positive regulation of early endosome to late endosome transport(GO:2000643) |
| 0.3 |
1.5 |
GO:0002283 |
neutrophil activation involved in immune response(GO:0002283) |
| 0.3 |
0.6 |
GO:0010725 |
regulation of primitive erythrocyte differentiation(GO:0010725) |
| 0.3 |
0.6 |
GO:0030007 |
cellular potassium ion homeostasis(GO:0030007) |
| 0.3 |
0.9 |
GO:0019676 |
ammonia assimilation cycle(GO:0019676) |
| 0.3 |
1.8 |
GO:0034080 |
CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
| 0.3 |
0.3 |
GO:0060438 |
trachea development(GO:0060438) |
| 0.3 |
1.8 |
GO:0033206 |
meiotic cytokinesis(GO:0033206) |
| 0.3 |
3.4 |
GO:0023041 |
neuronal signal transduction(GO:0023041) |
| 0.3 |
1.2 |
GO:0099527 |
postsynapse to nucleus signaling pathway(GO:0099527) |
| 0.3 |
1.8 |
GO:0045671 |
negative regulation of osteoclast differentiation(GO:0045671) |
| 0.3 |
1.5 |
GO:0043416 |
regulation of skeletal muscle tissue regeneration(GO:0043416) |
| 0.3 |
0.6 |
GO:0071545 |
inositol phosphate catabolic process(GO:0071545) |
| 0.3 |
0.3 |
GO:0051643 |
endoplasmic reticulum localization(GO:0051643) |
| 0.3 |
2.4 |
GO:0031547 |
brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
| 0.3 |
0.3 |
GO:0010694 |
positive regulation of alkaline phosphatase activity(GO:0010694) |
| 0.3 |
0.6 |
GO:0042097 |
interleukin-4 biosynthetic process(GO:0042097) regulation of interleukin-4 biosynthetic process(GO:0045402) |
| 0.3 |
1.2 |
GO:0007171 |
activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
| 0.3 |
0.9 |
GO:0035574 |
histone H4-K20 demethylation(GO:0035574) |
| 0.3 |
0.6 |
GO:0046719 |
regulation by virus of viral protein levels in host cell(GO:0046719) |
| 0.3 |
0.6 |
GO:0030011 |
maintenance of cell polarity(GO:0030011) |
| 0.3 |
0.6 |
GO:2000298 |
regulation of Rho-dependent protein serine/threonine kinase activity(GO:2000298) |
| 0.3 |
0.9 |
GO:0051152 |
positive regulation of smooth muscle cell differentiation(GO:0051152) |
| 0.3 |
0.3 |
GO:0003418 |
growth plate cartilage chondrocyte differentiation(GO:0003418) |
| 0.3 |
1.8 |
GO:1900028 |
negative regulation of ruffle assembly(GO:1900028) |
| 0.3 |
0.6 |
GO:0060414 |
aorta smooth muscle tissue morphogenesis(GO:0060414) |
| 0.3 |
0.9 |
GO:0097089 |
methyl-branched fatty acid metabolic process(GO:0097089) |
| 0.3 |
0.6 |
GO:0051132 |
NK T cell activation(GO:0051132) |
| 0.3 |
0.6 |
GO:0051754 |
meiotic sister chromatid cohesion, centromeric(GO:0051754) |
| 0.3 |
1.5 |
GO:0045607 |
regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
| 0.3 |
6.5 |
GO:0000387 |
spliceosomal snRNP assembly(GO:0000387) |
| 0.3 |
0.9 |
GO:1904719 |
excitatory chemical synaptic transmission(GO:0098976) positive regulation of AMPA glutamate receptor clustering(GO:1904719) |
| 0.3 |
2.1 |
GO:0034969 |
histone arginine methylation(GO:0034969) |
| 0.3 |
1.5 |
GO:0036480 |
neuron intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0036480) regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903376) |
| 0.3 |
0.3 |
GO:0018916 |
nitrobenzene metabolic process(GO:0018916) |
| 0.3 |
3.3 |
GO:0006465 |
signal peptide processing(GO:0006465) |
| 0.3 |
0.3 |
GO:0035694 |
mitochondrial protein catabolic process(GO:0035694) |
| 0.3 |
2.1 |
GO:0035584 |
calcium-mediated signaling using intracellular calcium source(GO:0035584) |
| 0.3 |
1.8 |
GO:0070423 |
nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway(GO:0035872) nucleotide-binding oligomerization domain containing signaling pathway(GO:0070423) nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070431) |
| 0.3 |
0.9 |
GO:0002580 |
regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002580) |
| 0.3 |
0.9 |
GO:1904778 |
regulation of protein localization to cell cortex(GO:1904776) positive regulation of protein localization to cell cortex(GO:1904778) |
| 0.3 |
1.2 |
GO:0000460 |
maturation of 5.8S rRNA(GO:0000460) |
| 0.3 |
9.4 |
GO:0007218 |
neuropeptide signaling pathway(GO:0007218) |
| 0.3 |
1.8 |
GO:0071494 |
cellular response to UV-C(GO:0071494) |
| 0.3 |
2.3 |
GO:1903298 |
regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903297) negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903298) intrinsic apoptotic signaling pathway in response to hypoxia(GO:1990144) |
| 0.3 |
0.9 |
GO:0030860 |
regulation of polarized epithelial cell differentiation(GO:0030860) |
| 0.3 |
0.6 |
GO:0043587 |
tongue morphogenesis(GO:0043587) |
| 0.3 |
0.9 |
GO:0043403 |
skeletal muscle tissue regeneration(GO:0043403) |
| 0.3 |
0.3 |
GO:0051131 |
chaperone-mediated protein complex assembly(GO:0051131) |
| 0.3 |
0.6 |
GO:0006659 |
phosphatidylserine biosynthetic process(GO:0006659) |
| 0.3 |
0.9 |
GO:1900060 |
negative regulation of ceramide biosynthetic process(GO:1900060) |
| 0.3 |
0.3 |
GO:0060423 |
foregut regionalization(GO:0060423) lung field specification(GO:0060424) lung induction(GO:0060492) |
| 0.3 |
0.3 |
GO:0045070 |
positive regulation of viral genome replication(GO:0045070) |
| 0.3 |
0.9 |
GO:0031508 |
pericentric heterochromatin assembly(GO:0031508) |
| 0.3 |
5.8 |
GO:0006825 |
copper ion transport(GO:0006825) |
| 0.3 |
2.6 |
GO:0038203 |
TORC2 signaling(GO:0038203) |
| 0.3 |
0.3 |
GO:0007181 |
transforming growth factor beta receptor complex assembly(GO:0007181) |
| 0.3 |
5.2 |
GO:0030513 |
positive regulation of BMP signaling pathway(GO:0030513) |
| 0.3 |
0.3 |
GO:0044828 |
negative regulation by host of viral genome replication(GO:0044828) |
| 0.3 |
0.3 |
GO:0042755 |
eating behavior(GO:0042755) |
| 0.3 |
2.9 |
GO:0022615 |
protein to membrane docking(GO:0022615) |
| 0.3 |
0.3 |
GO:2000275 |
regulation of oxidative phosphorylation uncoupler activity(GO:2000275) |
| 0.3 |
1.4 |
GO:0035469 |
determination of pancreatic left/right asymmetry(GO:0035469) |
| 0.3 |
1.1 |
GO:0090073 |
positive regulation of protein homodimerization activity(GO:0090073) |
| 0.3 |
3.4 |
GO:0060052 |
neurofilament cytoskeleton organization(GO:0060052) |
| 0.3 |
1.7 |
GO:2000210 |
positive regulation of anoikis(GO:2000210) |
| 0.3 |
0.9 |
GO:0070317 |
negative regulation of G0 to G1 transition(GO:0070317) |
| 0.3 |
0.6 |
GO:0060648 |
mammary gland bud morphogenesis(GO:0060648) |
| 0.3 |
2.8 |
GO:0001731 |
formation of translation preinitiation complex(GO:0001731) |
| 0.3 |
0.9 |
GO:0002922 |
positive regulation of humoral immune response(GO:0002922) |
| 0.3 |
0.8 |
GO:0010724 |
regulation of definitive erythrocyte differentiation(GO:0010724) |
| 0.3 |
0.8 |
GO:0000957 |
mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
| 0.3 |
2.3 |
GO:0042573 |
retinoic acid metabolic process(GO:0042573) |
| 0.3 |
0.6 |
GO:1902914 |
regulation of protein polyubiquitination(GO:1902914) positive regulation of protein polyubiquitination(GO:1902916) |
| 0.3 |
0.6 |
GO:0046101 |
hypoxanthine metabolic process(GO:0046100) hypoxanthine biosynthetic process(GO:0046101) |
| 0.3 |
0.8 |
GO:1905247 |
positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902961) positive regulation of aspartic-type peptidase activity(GO:1905247) |
| 0.3 |
0.3 |
GO:0021849 |
neuroblast division in subventricular zone(GO:0021849) |
| 0.3 |
0.3 |
GO:0018307 |
enzyme active site formation(GO:0018307) |
| 0.3 |
0.6 |
GO:1900037 |
regulation of cellular response to hypoxia(GO:1900037) |
| 0.3 |
2.8 |
GO:0006123 |
mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
| 0.3 |
0.3 |
GO:0000469 |
cleavage involved in rRNA processing(GO:0000469) |
| 0.3 |
1.1 |
GO:0051967 |
negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
| 0.3 |
2.8 |
GO:0007042 |
lysosomal lumen acidification(GO:0007042) |
| 0.3 |
2.2 |
GO:0090043 |
regulation of tubulin deacetylation(GO:0090043) |
| 0.3 |
1.1 |
GO:0000379 |
tRNA-type intron splice site recognition and cleavage(GO:0000379) |
| 0.3 |
1.1 |
GO:0042373 |
vitamin K metabolic process(GO:0042373) |
| 0.3 |
0.5 |
GO:0072708 |
response to sorbitol(GO:0072708) |
| 0.3 |
0.3 |
GO:0061101 |
neuroendocrine cell differentiation(GO:0061101) |
| 0.3 |
0.3 |
GO:0061013 |
regulation of mRNA catabolic process(GO:0061013) |
| 0.3 |
0.3 |
GO:0044851 |
hair cycle phase(GO:0044851) |
| 0.3 |
1.9 |
GO:0034308 |
primary alcohol metabolic process(GO:0034308) |
| 0.3 |
0.3 |
GO:0016332 |
establishment or maintenance of polarity of embryonic epithelium(GO:0016332) |
| 0.3 |
1.1 |
GO:0006751 |
glutathione catabolic process(GO:0006751) |
| 0.3 |
0.8 |
GO:0090285 |
negative regulation of protein glycosylation in Golgi(GO:0090285) |
| 0.3 |
1.6 |
GO:0046826 |
negative regulation of protein export from nucleus(GO:0046826) |
| 0.3 |
0.3 |
GO:0055095 |
lipoprotein particle mediated signaling(GO:0055095) low-density lipoprotein particle mediated signaling(GO:0055096) |
| 0.3 |
1.4 |
GO:0032463 |
negative regulation of protein homooligomerization(GO:0032463) |
| 0.3 |
0.3 |
GO:0099550 |
trans-synaptic signalling, modulating synaptic transmission(GO:0099550) |
| 0.3 |
0.3 |
GO:0060743 |
epithelial cell maturation involved in prostate gland development(GO:0060743) |
| 0.3 |
0.8 |
GO:0033615 |
mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
| 0.3 |
1.4 |
GO:0044829 |
positive regulation by host of viral genome replication(GO:0044829) |
| 0.3 |
0.5 |
GO:0010886 |
regulation of cholesterol storage(GO:0010885) positive regulation of cholesterol storage(GO:0010886) |
| 0.3 |
0.5 |
GO:0061055 |
myotome development(GO:0061055) |
| 0.3 |
4.3 |
GO:0019835 |
cytolysis(GO:0019835) |
| 0.3 |
0.8 |
GO:0010986 |
positive regulation of lipoprotein particle clearance(GO:0010986) |
| 0.3 |
1.1 |
GO:0090201 |
negative regulation of release of cytochrome c from mitochondria(GO:0090201) |
| 0.3 |
1.6 |
GO:0035435 |
phosphate ion transmembrane transport(GO:0035435) |
| 0.3 |
1.1 |
GO:0060056 |
mammary gland involution(GO:0060056) |
| 0.3 |
3.2 |
GO:0006995 |
cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
| 0.3 |
0.5 |
GO:0060594 |
mammary gland specification(GO:0060594) |
| 0.3 |
0.8 |
GO:0061357 |
Wnt protein secretion(GO:0061355) regulation of Wnt protein secretion(GO:0061356) positive regulation of Wnt protein secretion(GO:0061357) |
| 0.3 |
0.5 |
GO:0006166 |
purine ribonucleoside salvage(GO:0006166) |
| 0.3 |
3.7 |
GO:1902236 |
negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902236) |
| 0.3 |
1.9 |
GO:0015959 |
diadenosine polyphosphate metabolic process(GO:0015959) |
| 0.3 |
2.1 |
GO:0006398 |
mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
| 0.3 |
1.3 |
GO:0018195 |
peptidyl-arginine modification(GO:0018195) |
| 0.3 |
1.1 |
GO:0038128 |
ERBB2 signaling pathway(GO:0038128) |
| 0.3 |
0.8 |
GO:0043589 |
skin morphogenesis(GO:0043589) |
| 0.3 |
0.8 |
GO:0090004 |
positive regulation of Golgi to plasma membrane protein transport(GO:0042998) positive regulation of establishment of protein localization to plasma membrane(GO:0090004) |
| 0.3 |
0.8 |
GO:0090160 |
Golgi to lysosome transport(GO:0090160) |
| 0.3 |
0.8 |
GO:0090235 |
regulation of metaphase plate congression(GO:0090235) |
| 0.3 |
0.5 |
GO:0045410 |
positive regulation of interleukin-6 biosynthetic process(GO:0045410) |
| 0.3 |
2.4 |
GO:0031639 |
plasminogen activation(GO:0031639) |
| 0.3 |
1.8 |
GO:0045176 |
apical protein localization(GO:0045176) |
| 0.3 |
0.3 |
GO:0043555 |
regulation of translation in response to stress(GO:0043555) |
| 0.3 |
0.8 |
GO:0006924 |
activation-induced cell death of T cells(GO:0006924) |
| 0.3 |
3.9 |
GO:0050832 |
defense response to fungus(GO:0050832) |
| 0.3 |
1.0 |
GO:0060261 |
positive regulation of transcription initiation from RNA polymerase II promoter(GO:0060261) |
| 0.3 |
2.9 |
GO:0001990 |
regulation of systemic arterial blood pressure by hormone(GO:0001990) |
| 0.3 |
5.2 |
GO:0016226 |
iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
| 0.3 |
1.6 |
GO:0071493 |
cellular response to UV-B(GO:0071493) |
| 0.3 |
0.3 |
GO:0060017 |
parathyroid gland development(GO:0060017) |
| 0.3 |
3.4 |
GO:0048280 |
vesicle fusion with Golgi apparatus(GO:0048280) |
| 0.3 |
0.3 |
GO:0035726 |
common myeloid progenitor cell proliferation(GO:0035726) |
| 0.3 |
0.8 |
GO:0019348 |
dolichol metabolic process(GO:0019348) |
| 0.3 |
0.5 |
GO:1902661 |
regulation of glucose mediated signaling pathway(GO:1902659) positive regulation of glucose mediated signaling pathway(GO:1902661) |
| 0.3 |
1.0 |
GO:1902268 |
negative regulation of polyamine transmembrane transport(GO:1902268) |
| 0.3 |
0.5 |
GO:0045776 |
negative regulation of blood pressure(GO:0045776) |
| 0.3 |
2.1 |
GO:0031069 |
hair follicle morphogenesis(GO:0031069) |
| 0.3 |
3.9 |
GO:0030150 |
protein import into mitochondrial matrix(GO:0030150) |
| 0.3 |
2.1 |
GO:0040034 |
regulation of development, heterochronic(GO:0040034) |
| 0.3 |
0.8 |
GO:0010668 |
ectodermal cell differentiation(GO:0010668) |
| 0.3 |
0.8 |
GO:0009446 |
putrescine biosynthetic process(GO:0009446) |
| 0.3 |
0.8 |
GO:1904211 |
membrane protein proteolysis involved in retrograde protein transport, ER to cytosol(GO:1904211) |
| 0.3 |
0.3 |
GO:0071680 |
response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
| 0.3 |
0.3 |
GO:0009948 |
anterior/posterior axis specification(GO:0009948) |
| 0.3 |
0.3 |
GO:1990441 |
negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990441) |
| 0.3 |
0.5 |
GO:0006625 |
protein targeting to peroxisome(GO:0006625) peroxisomal transport(GO:0043574) protein localization to peroxisome(GO:0072662) establishment of protein localization to peroxisome(GO:0072663) |
| 0.3 |
1.8 |
GO:0005513 |
detection of calcium ion(GO:0005513) |
| 0.3 |
0.3 |
GO:0061484 |
hematopoietic stem cell homeostasis(GO:0061484) |
| 0.3 |
0.3 |
GO:0016093 |
polyprenol metabolic process(GO:0016093) |
| 0.3 |
0.8 |
GO:0000715 |
nucleotide-excision repair, DNA damage recognition(GO:0000715) |
| 0.2 |
0.7 |
GO:0032692 |
negative regulation of interleukin-1 production(GO:0032692) |
| 0.2 |
0.5 |
GO:0006977 |
DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) |
| 0.2 |
1.2 |
GO:0098703 |
calcium ion import across plasma membrane(GO:0098703) calcium ion import into cell(GO:1990035) |
| 0.2 |
0.7 |
GO:1903237 |
negative regulation of leukocyte tethering or rolling(GO:1903237) |
| 0.2 |
1.2 |
GO:0034122 |
negative regulation of toll-like receptor signaling pathway(GO:0034122) |
| 0.2 |
0.2 |
GO:0046718 |
viral entry into host cell(GO:0046718) |
| 0.2 |
0.7 |
GO:0006657 |
CDP-choline pathway(GO:0006657) |
| 0.2 |
1.0 |
GO:0060040 |
retinal bipolar neuron differentiation(GO:0060040) |
| 0.2 |
0.5 |
GO:0006419 |
alanyl-tRNA aminoacylation(GO:0006419) |
| 0.2 |
2.7 |
GO:0006337 |
nucleosome disassembly(GO:0006337) |
| 0.2 |
0.2 |
GO:1900368 |
regulation of RNA interference(GO:1900368) |
| 0.2 |
0.7 |
GO:0098974 |
postsynaptic actin cytoskeleton organization(GO:0098974) |
| 0.2 |
1.2 |
GO:0045039 |
protein import into mitochondrial inner membrane(GO:0045039) |
| 0.2 |
0.7 |
GO:0060368 |
regulation of Fc receptor mediated stimulatory signaling pathway(GO:0060368) |
| 0.2 |
0.7 |
GO:0048873 |
homeostasis of number of cells within a tissue(GO:0048873) |
| 0.2 |
1.9 |
GO:0036296 |
cellular response to increased oxygen levels(GO:0036295) response to increased oxygen levels(GO:0036296) |
| 0.2 |
0.7 |
GO:0006597 |
spermine biosynthetic process(GO:0006597) |
| 0.2 |
0.2 |
GO:0072592 |
oxygen metabolic process(GO:0072592) |
| 0.2 |
0.2 |
GO:0032070 |
regulation of deoxyribonuclease activity(GO:0032070) |
| 0.2 |
2.9 |
GO:0006120 |
mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
| 0.2 |
2.9 |
GO:0046036 |
CTP biosynthetic process(GO:0006241) CTP metabolic process(GO:0046036) |
| 0.2 |
1.7 |
GO:0033567 |
DNA replication, Okazaki fragment processing(GO:0033567) |
| 0.2 |
1.0 |
GO:0045838 |
positive regulation of membrane potential(GO:0045838) |
| 0.2 |
1.4 |
GO:0048102 |
autophagic cell death(GO:0048102) |
| 0.2 |
1.9 |
GO:1900025 |
negative regulation of substrate adhesion-dependent cell spreading(GO:1900025) |
| 0.2 |
0.2 |
GO:0061763 |
multivesicular body-lysosome fusion(GO:0061763) |
| 0.2 |
0.2 |
GO:0045658 |
regulation of neutrophil differentiation(GO:0045658) negative regulation of neutrophil differentiation(GO:0045659) |
| 0.2 |
0.7 |
GO:0036509 |
trimming of terminal mannose on B branch(GO:0036509) |
| 0.2 |
0.2 |
GO:0031290 |
retinal ganglion cell axon guidance(GO:0031290) |
| 0.2 |
0.7 |
GO:1904685 |
positive regulation of metalloendopeptidase activity(GO:1904685) |
| 0.2 |
0.2 |
GO:0019074 |
viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
| 0.2 |
0.5 |
GO:0031223 |
auditory behavior(GO:0031223) |
| 0.2 |
0.2 |
GO:0002347 |
response to tumor cell(GO:0002347) |
| 0.2 |
0.2 |
GO:0002208 |
somatic recombination of immunoglobulin genes involved in immune response(GO:0002204) somatic diversification of immunoglobulins involved in immune response(GO:0002208) isotype switching(GO:0045190) |
| 0.2 |
0.2 |
GO:0031915 |
positive regulation of synaptic plasticity(GO:0031915) |
| 0.2 |
0.9 |
GO:0009264 |
deoxyribonucleotide catabolic process(GO:0009264) |
| 0.2 |
0.2 |
GO:0071243 |
cellular response to arsenic-containing substance(GO:0071243) |
| 0.2 |
1.9 |
GO:0043615 |
astrocyte cell migration(GO:0043615) |
| 0.2 |
0.9 |
GO:0007196 |
adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
| 0.2 |
1.6 |
GO:0036506 |
maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
| 0.2 |
0.7 |
GO:0001180 |
transcription initiation from RNA polymerase I promoter for nuclear large rRNA transcript(GO:0001180) |
| 0.2 |
0.5 |
GO:0035617 |
stress granule disassembly(GO:0035617) |
| 0.2 |
0.2 |
GO:0061188 |
regulation of chromatin silencing at rDNA(GO:0061187) negative regulation of chromatin silencing at rDNA(GO:0061188) |
| 0.2 |
0.5 |
GO:2000781 |
positive regulation of double-strand break repair(GO:2000781) |
| 0.2 |
0.7 |
GO:0097152 |
mesenchymal cell apoptotic process(GO:0097152) |
| 0.2 |
1.2 |
GO:0006598 |
polyamine catabolic process(GO:0006598) |
| 0.2 |
0.7 |
GO:0042362 |
fat-soluble vitamin biosynthetic process(GO:0042362) |
| 0.2 |
0.9 |
GO:0070934 |
CRD-mediated mRNA stabilization(GO:0070934) |
| 0.2 |
0.9 |
GO:0032493 |
response to bacterial lipoprotein(GO:0032493) |
| 0.2 |
0.7 |
GO:0030327 |
prenylated protein catabolic process(GO:0030327) |
| 0.2 |
0.5 |
GO:0036292 |
DNA rewinding(GO:0036292) |
| 0.2 |
0.9 |
GO:0033540 |
fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
| 0.2 |
6.9 |
GO:0000462 |
maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
| 0.2 |
0.2 |
GO:0021800 |
cerebral cortex tangential migration(GO:0021800) |
| 0.2 |
2.3 |
GO:0071378 |
growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
| 0.2 |
0.9 |
GO:0006014 |
D-ribose metabolic process(GO:0006014) |
| 0.2 |
2.1 |
GO:0001682 |
tRNA 5'-leader removal(GO:0001682) |
| 0.2 |
2.5 |
GO:0070935 |
3'-UTR-mediated mRNA stabilization(GO:0070935) |
| 0.2 |
1.1 |
GO:0090164 |
asymmetric Golgi ribbon formation(GO:0090164) |
| 0.2 |
0.2 |
GO:0061217 |
positive regulation of mesonephros development(GO:0061213) regulation of mesonephros development(GO:0061217) |
| 0.2 |
0.7 |
GO:2000195 |
negative regulation of female gonad development(GO:2000195) |
| 0.2 |
3.0 |
GO:0008535 |
respiratory chain complex IV assembly(GO:0008535) |
| 0.2 |
0.2 |
GO:0016114 |
terpenoid biosynthetic process(GO:0016114) |
| 0.2 |
0.7 |
GO:0008300 |
isoprenoid catabolic process(GO:0008300) |
| 0.2 |
0.5 |
GO:0036166 |
phenotypic switching(GO:0036166) |
| 0.2 |
2.3 |
GO:0006388 |
tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
| 0.2 |
5.0 |
GO:0006910 |
phagocytosis, recognition(GO:0006910) |
| 0.2 |
13.3 |
GO:0009142 |
nucleoside triphosphate biosynthetic process(GO:0009142) |
| 0.2 |
0.2 |
GO:0072553 |
terminal button organization(GO:0072553) |
| 0.2 |
0.9 |
GO:0072675 |
osteoclast fusion(GO:0072675) |
| 0.2 |
0.2 |
GO:0051014 |
actin filament severing(GO:0051014) |
| 0.2 |
0.9 |
GO:0060709 |
glycogen cell differentiation involved in embryonic placenta development(GO:0060709) |
| 0.2 |
1.1 |
GO:0007080 |
mitotic metaphase plate congression(GO:0007080) |
| 0.2 |
0.7 |
GO:1903644 |
regulation of chaperone-mediated protein folding(GO:1903644) |
| 0.2 |
3.4 |
GO:0048026 |
positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
| 0.2 |
0.4 |
GO:0030644 |
cellular chloride ion homeostasis(GO:0030644) |
| 0.2 |
0.4 |
GO:0030997 |
regulation of centriole-centriole cohesion(GO:0030997) |
| 0.2 |
0.4 |
GO:1903903 |
regulation of establishment of T cell polarity(GO:1903903) |
| 0.2 |
0.7 |
GO:0000972 |
transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
| 0.2 |
0.7 |
GO:0006285 |
base-excision repair, AP site formation(GO:0006285) |
| 0.2 |
2.7 |
GO:0007007 |
inner mitochondrial membrane organization(GO:0007007) |
| 0.2 |
4.0 |
GO:0071353 |
cellular response to interleukin-4(GO:0071353) |
| 0.2 |
0.2 |
GO:1903630 |
regulation of aminoacyl-tRNA ligase activity(GO:1903630) positive regulation of aminoacyl-tRNA ligase activity(GO:1903632) |
| 0.2 |
2.0 |
GO:0032225 |
regulation of synaptic transmission, dopaminergic(GO:0032225) |
| 0.2 |
1.3 |
GO:0032776 |
DNA methylation on cytosine(GO:0032776) |
| 0.2 |
1.1 |
GO:0033227 |
dsRNA transport(GO:0033227) |
| 0.2 |
0.9 |
GO:0006421 |
asparaginyl-tRNA aminoacylation(GO:0006421) |
| 0.2 |
1.1 |
GO:0036123 |
histone H3-K9 dimethylation(GO:0036123) |
| 0.2 |
0.9 |
GO:0032055 |
negative regulation of translation in response to stress(GO:0032055) |
| 0.2 |
0.2 |
GO:1901300 |
positive regulation of hydrogen peroxide-mediated programmed cell death(GO:1901300) |
| 0.2 |
0.2 |
GO:1902498 |
regulation of protein autoubiquitination(GO:1902498) |
| 0.2 |
0.7 |
GO:0009052 |
pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
| 0.2 |
0.7 |
GO:0051036 |
regulation of endosome size(GO:0051036) |
| 0.2 |
0.2 |
GO:0016188 |
synaptic vesicle maturation(GO:0016188) |
| 0.2 |
11.1 |
GO:0002181 |
cytoplasmic translation(GO:0002181) |
| 0.2 |
1.1 |
GO:0090168 |
Golgi reassembly(GO:0090168) |
| 0.2 |
3.5 |
GO:0001921 |
positive regulation of receptor recycling(GO:0001921) |
| 0.2 |
0.4 |
GO:1903490 |
regulation of cytokinetic process(GO:0032954) regulation of mitotic cytokinetic process(GO:1903436) positive regulation of mitotic cytokinetic process(GO:1903438) positive regulation of mitotic cytokinesis(GO:1903490) |
| 0.2 |
1.5 |
GO:0060670 |
branching involved in labyrinthine layer morphogenesis(GO:0060670) |
| 0.2 |
3.5 |
GO:0001893 |
maternal placenta development(GO:0001893) |
| 0.2 |
0.4 |
GO:0043117 |
positive regulation of vascular permeability(GO:0043117) |
| 0.2 |
1.3 |
GO:0003096 |
renal sodium ion transport(GO:0003096) |
| 0.2 |
1.1 |
GO:0034975 |
protein folding in endoplasmic reticulum(GO:0034975) |
| 0.2 |
0.9 |
GO:0019287 |
isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
| 0.2 |
1.3 |
GO:0051255 |
spindle midzone assembly(GO:0051255) |
| 0.2 |
0.6 |
GO:0001193 |
maintenance of transcriptional fidelity during DNA-templated transcription elongation(GO:0001192) maintenance of transcriptional fidelity during DNA-templated transcription elongation from RNA polymerase II promoter(GO:0001193) |
| 0.2 |
7.7 |
GO:0033108 |
mitochondrial respiratory chain complex assembly(GO:0033108) |
| 0.2 |
0.2 |
GO:0097211 |
response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
| 0.2 |
0.4 |
GO:0034196 |
acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
| 0.2 |
1.3 |
GO:0016255 |
attachment of GPI anchor to protein(GO:0016255) |
| 0.2 |
0.2 |
GO:0002432 |
granuloma formation(GO:0002432) |
| 0.2 |
0.6 |
GO:0046598 |
positive regulation of viral entry into host cell(GO:0046598) |
| 0.2 |
3.0 |
GO:0045663 |
positive regulation of myoblast differentiation(GO:0045663) |
| 0.2 |
0.6 |
GO:0090241 |
negative regulation of histone H4 acetylation(GO:0090241) |
| 0.2 |
0.2 |
GO:0006538 |
glutamate catabolic process(GO:0006538) |
| 0.2 |
0.4 |
GO:0045657 |
positive regulation of monocyte differentiation(GO:0045657) |
| 0.2 |
1.5 |
GO:0033631 |
cell-cell adhesion mediated by integrin(GO:0033631) |
| 0.2 |
0.2 |
GO:0090177 |
establishment of planar polarity involved in neural tube closure(GO:0090177) |
| 0.2 |
1.9 |
GO:0010832 |
negative regulation of myotube differentiation(GO:0010832) |
| 0.2 |
1.5 |
GO:2000491 |
positive regulation of hepatic stellate cell activation(GO:2000491) |
| 0.2 |
0.4 |
GO:0030224 |
monocyte differentiation(GO:0030224) |
| 0.2 |
0.2 |
GO:0019244 |
lactate biosynthetic process from pyruvate(GO:0019244) |
| 0.2 |
0.6 |
GO:0001869 |
regulation of complement activation, lectin pathway(GO:0001868) negative regulation of complement activation, lectin pathway(GO:0001869) |
| 0.2 |
1.3 |
GO:0070099 |
regulation of chemokine-mediated signaling pathway(GO:0070099) negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
| 0.2 |
4.6 |
GO:0045746 |
negative regulation of Notch signaling pathway(GO:0045746) |
| 0.2 |
0.2 |
GO:0000821 |
regulation of arginine metabolic process(GO:0000821) |
| 0.2 |
1.7 |
GO:0006450 |
regulation of translational fidelity(GO:0006450) |
| 0.2 |
0.6 |
GO:0097029 |
mature conventional dendritic cell differentiation(GO:0097029) |
| 0.2 |
0.4 |
GO:0044872 |
lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
| 0.2 |
2.1 |
GO:0051352 |
negative regulation of ligase activity(GO:0051352) negative regulation of ubiquitin-protein transferase activity(GO:0051444) |
| 0.2 |
0.6 |
GO:0030202 |
heparin metabolic process(GO:0030202) |
| 0.2 |
0.6 |
GO:0030208 |
dermatan sulfate biosynthetic process(GO:0030208) |
| 0.2 |
0.2 |
GO:0022616 |
DNA strand elongation(GO:0022616) |
| 0.2 |
2.3 |
GO:0006750 |
glutathione biosynthetic process(GO:0006750) |
| 0.2 |
1.0 |
GO:0042256 |
mature ribosome assembly(GO:0042256) |
| 0.2 |
0.6 |
GO:0046462 |
monoacylglycerol metabolic process(GO:0046462) |
| 0.2 |
0.8 |
GO:0072683 |
T cell extravasation(GO:0072683) |
| 0.2 |
0.2 |
GO:0051561 |
positive regulation of mitochondrial calcium ion concentration(GO:0051561) |
| 0.2 |
0.8 |
GO:0021812 |
neuronal-glial interaction involved in cerebral cortex radial glia guided migration(GO:0021812) |
| 0.2 |
0.6 |
GO:0030049 |
muscle filament sliding(GO:0030049) |
| 0.2 |
2.4 |
GO:0070936 |
protein K48-linked ubiquitination(GO:0070936) |
| 0.2 |
3.7 |
GO:0016339 |
calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
| 0.2 |
0.4 |
GO:0002309 |
T cell proliferation involved in immune response(GO:0002309) |
| 0.2 |
1.8 |
GO:0006107 |
oxaloacetate metabolic process(GO:0006107) |
| 0.2 |
0.2 |
GO:0010360 |
regulation of anion channel activity(GO:0010359) negative regulation of anion channel activity(GO:0010360) |
| 0.2 |
2.6 |
GO:0051016 |
barbed-end actin filament capping(GO:0051016) |
| 0.2 |
0.2 |
GO:0030656 |
regulation of vitamin metabolic process(GO:0030656) |
| 0.2 |
3.4 |
GO:0021978 |
telencephalon regionalization(GO:0021978) |
| 0.2 |
0.2 |
GO:0046037 |
GMP metabolic process(GO:0046037) |
| 0.2 |
8.5 |
GO:0045454 |
cell redox homeostasis(GO:0045454) |
| 0.2 |
1.2 |
GO:1903975 |
regulation of glial cell migration(GO:1903975) |
| 0.2 |
0.2 |
GO:0008078 |
mesodermal cell migration(GO:0008078) |
| 0.2 |
0.4 |
GO:1900038 |
negative regulation of cellular response to hypoxia(GO:1900038) |
| 0.2 |
0.4 |
GO:1903779 |
regulation of cardiac conduction(GO:1903779) |
| 0.2 |
0.4 |
GO:0044068 |
modulation by symbiont of host cellular process(GO:0044068) |
| 0.2 |
0.8 |
GO:0046909 |
intermembrane transport(GO:0046909) protein transport from ciliary membrane to plasma membrane(GO:1903445) |
| 0.2 |
2.6 |
GO:0060482 |
lobar bronchus development(GO:0060482) |
| 0.2 |
0.4 |
GO:0043031 |
negative regulation of macrophage activation(GO:0043031) |
| 0.2 |
0.2 |
GO:1902525 |
regulation of protein monoubiquitination(GO:1902525) |
| 0.2 |
2.6 |
GO:0051123 |
RNA polymerase II transcriptional preinitiation complex assembly(GO:0051123) |
| 0.2 |
0.6 |
GO:0086067 |
AV node cell to bundle of His cell communication(GO:0086067) |
| 0.2 |
4.0 |
GO:0006783 |
heme biosynthetic process(GO:0006783) |
| 0.2 |
0.8 |
GO:1900533 |
medium-chain fatty-acyl-CoA catabolic process(GO:0036114) fatty-acyl-CoA catabolic process(GO:0036115) long-chain fatty-acyl-CoA catabolic process(GO:0036116) palmitic acid metabolic process(GO:1900533) palmitic acid biosynthetic process(GO:1900535) |
| 0.2 |
0.2 |
GO:0010936 |
negative regulation of macrophage cytokine production(GO:0010936) |
| 0.2 |
0.6 |
GO:0034473 |
U1 snRNA 3'-end processing(GO:0034473) U5 snRNA 3'-end processing(GO:0034476) nuclear polyadenylation-dependent mRNA catabolic process(GO:0071042) polyadenylation-dependent mRNA catabolic process(GO:0071047) |
| 0.2 |
0.2 |
GO:0045716 |
positive regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045716) |
| 0.2 |
0.8 |
GO:1903317 |
regulation of protein maturation(GO:1903317) |
| 0.2 |
0.8 |
GO:1903966 |
monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
| 0.2 |
0.6 |
GO:2000048 |
negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
| 0.2 |
1.6 |
GO:2000786 |
positive regulation of autophagosome assembly(GO:2000786) |
| 0.2 |
3.3 |
GO:0051764 |
actin crosslink formation(GO:0051764) |
| 0.2 |
1.8 |
GO:0007096 |
regulation of exit from mitosis(GO:0007096) |
| 0.2 |
0.4 |
GO:0009215 |
purine deoxyribonucleoside triphosphate metabolic process(GO:0009215) |
| 0.2 |
0.8 |
GO:0002667 |
lymphocyte anergy(GO:0002249) regulation of T cell anergy(GO:0002667) T cell anergy(GO:0002870) regulation of lymphocyte anergy(GO:0002911) |
| 0.2 |
0.4 |
GO:0060766 |
negative regulation of androgen receptor signaling pathway(GO:0060766) |
| 0.2 |
0.4 |
GO:0035964 |
COPI-coated vesicle budding(GO:0035964) |
| 0.2 |
0.6 |
GO:0006983 |
ER overload response(GO:0006983) |
| 0.2 |
4.7 |
GO:0010718 |
positive regulation of epithelial to mesenchymal transition(GO:0010718) |
| 0.2 |
0.2 |
GO:0097476 |
spinal cord motor neuron migration(GO:0097476) |
| 0.2 |
0.4 |
GO:0060068 |
vagina development(GO:0060068) |
| 0.2 |
2.5 |
GO:0009312 |
oligosaccharide biosynthetic process(GO:0009312) |
| 0.2 |
0.2 |
GO:2001185 |
regulation of CD8-positive, alpha-beta T cell activation(GO:2001185) |
| 0.2 |
1.3 |
GO:0036444 |
calcium ion transmembrane import into mitochondrion(GO:0036444) |
| 0.2 |
0.2 |
GO:0071649 |
regulation of chemokine (C-C motif) ligand 5 production(GO:0071649) |
| 0.2 |
2.1 |
GO:0071447 |
cellular response to hydroperoxide(GO:0071447) |
| 0.2 |
0.8 |
GO:0014005 |
microglia differentiation(GO:0014004) microglia development(GO:0014005) |
| 0.2 |
0.2 |
GO:0070966 |
nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
| 0.2 |
0.4 |
GO:1900027 |
regulation of ruffle assembly(GO:1900027) |
| 0.2 |
1.3 |
GO:0051292 |
nuclear pore complex assembly(GO:0051292) |
| 0.2 |
0.4 |
GO:0002946 |
tRNA C5-cytosine methylation(GO:0002946) |
| 0.2 |
0.6 |
GO:0009162 |
deoxyribonucleoside monophosphate metabolic process(GO:0009162) |
| 0.2 |
0.2 |
GO:0061144 |
alveolar secondary septum development(GO:0061144) |
| 0.2 |
0.6 |
GO:0006624 |
vacuolar protein processing(GO:0006624) |
| 0.2 |
0.8 |
GO:0097298 |
regulation of nucleus size(GO:0097298) |
| 0.2 |
0.6 |
GO:0031424 |
keratinization(GO:0031424) |
| 0.2 |
0.6 |
GO:0019370 |
leukotriene biosynthetic process(GO:0019370) |
| 0.2 |
0.2 |
GO:0003357 |
noradrenergic neuron differentiation(GO:0003357) |
| 0.2 |
0.7 |
GO:0006741 |
NADP biosynthetic process(GO:0006741) |
| 0.2 |
0.6 |
GO:0035547 |
interferon-beta secretion(GO:0035546) regulation of interferon-beta secretion(GO:0035547) positive regulation of interferon-beta secretion(GO:0035549) |
| 0.2 |
2.4 |
GO:0042775 |
mitochondrial ATP synthesis coupled electron transport(GO:0042775) |
| 0.2 |
0.7 |
GO:0042534 |
tumor necrosis factor biosynthetic process(GO:0042533) regulation of tumor necrosis factor biosynthetic process(GO:0042534) |
| 0.2 |
0.6 |
GO:1990414 |
replication-born double-strand break repair via sister chromatid exchange(GO:1990414) |
| 0.2 |
0.6 |
GO:0000290 |
deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
| 0.2 |
0.2 |
GO:0071816 |
tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
| 0.2 |
0.2 |
GO:0072143 |
mesangial cell differentiation(GO:0072007) glomerular mesangial cell differentiation(GO:0072008) mesangial cell development(GO:0072143) glomerular mesangial cell development(GO:0072144) |
| 0.2 |
0.6 |
GO:2001225 |
regulation of chloride transport(GO:2001225) |
| 0.2 |
0.7 |
GO:2000653 |
regulation of genetic imprinting(GO:2000653) |
| 0.2 |
0.2 |
GO:0014874 |
response to stimulus involved in regulation of muscle adaptation(GO:0014874) |
| 0.2 |
0.2 |
GO:0043568 |
positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
| 0.2 |
0.2 |
GO:0044241 |
lipid digestion(GO:0044241) |
| 0.2 |
0.4 |
GO:0032077 |
positive regulation of deoxyribonuclease activity(GO:0032077) |
| 0.2 |
0.7 |
GO:0006627 |
protein processing involved in protein targeting to mitochondrion(GO:0006627) |
| 0.2 |
1.3 |
GO:0035094 |
response to nicotine(GO:0035094) |
| 0.2 |
0.4 |
GO:0048368 |
paraxial mesoderm development(GO:0048339) lateral mesoderm development(GO:0048368) |
| 0.2 |
0.7 |
GO:0018242 |
protein O-linked glycosylation via serine(GO:0018242) |
| 0.2 |
1.5 |
GO:0046085 |
adenosine metabolic process(GO:0046085) |
| 0.2 |
0.7 |
GO:1902592 |
viral budding(GO:0046755) multi-organism organelle organization(GO:1902590) multi-organism membrane budding(GO:1902592) |
| 0.2 |
0.2 |
GO:0021562 |
vestibulocochlear nerve development(GO:0021562) |
| 0.2 |
0.2 |
GO:1904154 |
positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
| 0.2 |
0.4 |
GO:0006610 |
ribosomal protein import into nucleus(GO:0006610) |
| 0.2 |
1.3 |
GO:0035635 |
entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
| 0.2 |
1.1 |
GO:0015919 |
peroxisomal membrane transport(GO:0015919) protein import into peroxisome membrane(GO:0045046) |
| 0.2 |
2.1 |
GO:0000920 |
cell separation after cytokinesis(GO:0000920) |
| 0.2 |
1.2 |
GO:0042126 |
nitrate metabolic process(GO:0042126) |
| 0.2 |
0.2 |
GO:0002339 |
B cell selection(GO:0002339) |
| 0.2 |
1.1 |
GO:2001224 |
positive regulation of neuron migration(GO:2001224) |
| 0.2 |
1.4 |
GO:0001780 |
neutrophil homeostasis(GO:0001780) |
| 0.2 |
0.2 |
GO:0036499 |
PERK-mediated unfolded protein response(GO:0036499) |
| 0.2 |
0.4 |
GO:1902224 |
cellular ketone body metabolic process(GO:0046950) ketone body metabolic process(GO:1902224) |
| 0.2 |
0.7 |
GO:0019355 |
nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process(GO:0034627) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
| 0.2 |
0.5 |
GO:0060416 |
response to growth hormone(GO:0060416) |
| 0.2 |
0.2 |
GO:0072720 |
response to dithiothreitol(GO:0072720) |
| 0.2 |
0.5 |
GO:0006435 |
threonyl-tRNA aminoacylation(GO:0006435) |
| 0.2 |
0.4 |
GO:0007398 |
ectoderm development(GO:0007398) |
| 0.2 |
0.7 |
GO:0006788 |
heme oxidation(GO:0006788) |
| 0.2 |
0.7 |
GO:0097066 |
response to thyroid hormone(GO:0097066) |
| 0.2 |
0.2 |
GO:0035553 |
oxidative single-stranded RNA demethylation(GO:0035553) oxidative demethylation(GO:0070989) |
| 0.2 |
0.9 |
GO:1900016 |
negative regulation of cytokine production involved in inflammatory response(GO:1900016) |
| 0.2 |
0.2 |
GO:0003415 |
chondrocyte hypertrophy(GO:0003415) |
| 0.2 |
1.9 |
GO:0097284 |
hepatocyte apoptotic process(GO:0097284) |
| 0.2 |
0.7 |
GO:0039532 |
negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway(GO:0039532) |
| 0.2 |
0.3 |
GO:0042264 |
peptidyl-aspartic acid hydroxylation(GO:0042264) |
| 0.2 |
0.2 |
GO:1901420 |
negative regulation of response to alcohol(GO:1901420) |
| 0.2 |
0.2 |
GO:1904637 |
response to ionomycin(GO:1904636) cellular response to ionomycin(GO:1904637) |
| 0.2 |
1.6 |
GO:2000353 |
positive regulation of endothelial cell apoptotic process(GO:2000353) |
| 0.2 |
2.1 |
GO:0045722 |
positive regulation of gluconeogenesis(GO:0045722) |
| 0.2 |
2.2 |
GO:0031987 |
locomotion involved in locomotory behavior(GO:0031987) |
| 0.2 |
0.2 |
GO:1903894 |
regulation of IRE1-mediated unfolded protein response(GO:1903894) |
| 0.2 |
0.9 |
GO:0071786 |
endoplasmic reticulum tubular network organization(GO:0071786) |
| 0.2 |
0.5 |
GO:0071285 |
cellular response to lithium ion(GO:0071285) |
| 0.2 |
1.0 |
GO:1902513 |
regulation of organelle transport along microtubule(GO:1902513) |
| 0.2 |
2.5 |
GO:0006879 |
cellular iron ion homeostasis(GO:0006879) |
| 0.2 |
1.2 |
GO:0016185 |
synaptic vesicle budding from presynaptic endocytic zone membrane(GO:0016185) synaptic vesicle budding(GO:0070142) |
| 0.2 |
0.5 |
GO:0035457 |
cellular response to interferon-alpha(GO:0035457) |
| 0.2 |
5.2 |
GO:0034723 |
DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
| 0.2 |
0.5 |
GO:0008635 |
activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
| 0.2 |
0.7 |
GO:0007144 |
female meiosis I(GO:0007144) |
| 0.2 |
0.2 |
GO:2000822 |
regulation of fear response(GO:1903365) regulation of behavioral fear response(GO:2000822) |
| 0.2 |
0.8 |
GO:0031584 |
activation of phospholipase D activity(GO:0031584) |
| 0.2 |
0.5 |
GO:1903244 |
positive regulation of cardiac muscle adaptation(GO:0010615) positive regulation of cardiac muscle hypertrophy in response to stress(GO:1903244) |
| 0.2 |
1.0 |
GO:0006390 |
transcription from mitochondrial promoter(GO:0006390) |
| 0.2 |
0.7 |
GO:0072512 |
ferric iron transport(GO:0015682) trivalent inorganic cation transport(GO:0072512) |
| 0.2 |
2.2 |
GO:0035563 |
positive regulation of chromatin binding(GO:0035563) |
| 0.2 |
0.3 |
GO:0002710 |
negative regulation of T cell mediated immunity(GO:0002710) |
| 0.2 |
1.0 |
GO:0072048 |
pattern specification involved in kidney development(GO:0061004) renal system pattern specification(GO:0072048) |
| 0.2 |
0.5 |
GO:0051151 |
negative regulation of smooth muscle cell differentiation(GO:0051151) |
| 0.2 |
0.7 |
GO:0072319 |
vesicle uncoating(GO:0072319) |
| 0.2 |
1.0 |
GO:0042745 |
circadian sleep/wake cycle(GO:0042745) |
| 0.2 |
1.2 |
GO:0071763 |
nuclear membrane organization(GO:0071763) |
| 0.2 |
0.5 |
GO:0044778 |
meiotic DNA integrity checkpoint(GO:0044778) |
| 0.2 |
0.5 |
GO:0009169 |
purine nucleoside monophosphate catabolic process(GO:0009128) ribonucleoside monophosphate catabolic process(GO:0009158) purine ribonucleoside monophosphate catabolic process(GO:0009169) |
| 0.2 |
0.3 |
GO:1903054 |
negative regulation of extracellular matrix organization(GO:1903054) |
| 0.2 |
0.7 |
GO:0032020 |
ISG15-protein conjugation(GO:0032020) |
| 0.2 |
0.2 |
GO:1990927 |
calcium ion regulated lysosome exocytosis(GO:1990927) |
| 0.2 |
3.0 |
GO:0022900 |
electron transport chain(GO:0022900) |
| 0.2 |
1.1 |
GO:0033033 |
negative regulation of myeloid cell apoptotic process(GO:0033033) |
| 0.2 |
0.2 |
GO:0015817 |
histidine transport(GO:0015817) |
| 0.2 |
1.3 |
GO:0045624 |
positive regulation of T-helper cell differentiation(GO:0045624) |
| 0.2 |
0.7 |
GO:0006481 |
C-terminal protein methylation(GO:0006481) |
| 0.2 |
0.2 |
GO:0044805 |
late nucleophagy(GO:0044805) |
| 0.2 |
3.6 |
GO:0035335 |
peptidyl-tyrosine dephosphorylation(GO:0035335) |
| 0.2 |
1.0 |
GO:0006004 |
fucose metabolic process(GO:0006004) |
| 0.2 |
0.2 |
GO:0019395 |
fatty acid oxidation(GO:0019395) |
| 0.2 |
0.2 |
GO:0033262 |
regulation of nuclear cell cycle DNA replication(GO:0033262) |
| 0.2 |
0.3 |
GO:0001714 |
endodermal cell fate specification(GO:0001714) |
| 0.2 |
0.5 |
GO:0071035 |
nuclear ncRNA surveillance(GO:0071029) nuclear polyadenylation-dependent rRNA catabolic process(GO:0071035) nuclear polyadenylation-dependent ncRNA catabolic process(GO:0071046) |
| 0.2 |
0.5 |
GO:0006436 |
tryptophanyl-tRNA aminoacylation(GO:0006436) |
| 0.2 |
0.3 |
GO:2000114 |
regulation of establishment of cell polarity(GO:2000114) |
| 0.2 |
0.5 |
GO:0045578 |
negative regulation of B cell differentiation(GO:0045578) |
| 0.2 |
0.5 |
GO:0006669 |
sphinganine-1-phosphate biosynthetic process(GO:0006669) |
| 0.2 |
0.5 |
GO:0030421 |
defecation(GO:0030421) |
| 0.2 |
1.7 |
GO:0034244 |
negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
| 0.2 |
1.1 |
GO:0042984 |
amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) |
| 0.2 |
0.6 |
GO:2000574 |
regulation of microtubule motor activity(GO:2000574) |
| 0.2 |
0.5 |
GO:0042275 |
error-free postreplication DNA repair(GO:0042275) |
| 0.2 |
2.2 |
GO:0090662 |
ATP hydrolysis coupled transmembrane transport(GO:0090662) |
| 0.2 |
0.9 |
GO:0043518 |
negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) |
| 0.2 |
1.3 |
GO:0098967 |
exocytic insertion of neurotransmitter receptor to plasma membrane(GO:0098881) exocytic insertion of neurotransmitter receptor to postsynaptic membrane(GO:0098967) |
| 0.2 |
0.3 |
GO:0002176 |
male germ cell proliferation(GO:0002176) |
| 0.2 |
0.2 |
GO:0033239 |
negative regulation of cellular amine metabolic process(GO:0033239) |
| 0.2 |
0.6 |
GO:1903300 |
negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
| 0.2 |
0.3 |
GO:0034113 |
heterotypic cell-cell adhesion(GO:0034113) |
| 0.2 |
0.2 |
GO:0019046 |
release from viral latency(GO:0019046) |
| 0.2 |
1.7 |
GO:0008206 |
bile acid metabolic process(GO:0008206) |
| 0.2 |
0.2 |
GO:1990776 |
cellular response to angiotensin(GO:1904385) response to angiotensin(GO:1990776) |
| 0.2 |
3.7 |
GO:0000027 |
ribosomal large subunit assembly(GO:0000027) |
| 0.2 |
1.1 |
GO:0043162 |
ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
| 0.2 |
0.9 |
GO:0035269 |
protein O-linked mannosylation(GO:0035269) |
| 0.2 |
0.2 |
GO:0050975 |
sensory perception of touch(GO:0050975) |
| 0.2 |
2.2 |
GO:0010666 |
positive regulation of striated muscle cell apoptotic process(GO:0010663) positive regulation of cardiac muscle cell apoptotic process(GO:0010666) |
| 0.2 |
0.8 |
GO:1904263 |
positive regulation of TORC1 signaling(GO:1904263) |
| 0.2 |
0.2 |
GO:0003162 |
atrioventricular node development(GO:0003162) |
| 0.2 |
0.5 |
GO:0001661 |
conditioned taste aversion(GO:0001661) |
| 0.2 |
0.3 |
GO:0032509 |
endosome transport via multivesicular body sorting pathway(GO:0032509) |
| 0.2 |
0.2 |
GO:0036324 |
vascular endothelial growth factor receptor-2 signaling pathway(GO:0036324) |
| 0.2 |
0.5 |
GO:0006907 |
pinocytosis(GO:0006907) |
| 0.2 |
0.5 |
GO:0000389 |
mRNA 3'-splice site recognition(GO:0000389) |
| 0.2 |
0.3 |
GO:0071442 |
positive regulation of histone H3-K14 acetylation(GO:0071442) |
| 0.2 |
1.1 |
GO:0006654 |
phosphatidic acid biosynthetic process(GO:0006654) |
| 0.2 |
0.8 |
GO:0042473 |
outer ear morphogenesis(GO:0042473) |
| 0.2 |
0.2 |
GO:1990009 |
retinal cell apoptotic process(GO:1990009) |
| 0.2 |
0.6 |
GO:0006420 |
arginyl-tRNA aminoacylation(GO:0006420) |
| 0.2 |
0.6 |
GO:0040037 |
negative regulation of fibroblast growth factor receptor signaling pathway(GO:0040037) |
| 0.1 |
1.3 |
GO:0046596 |
regulation of viral entry into host cell(GO:0046596) |
| 0.1 |
0.7 |
GO:0018364 |
peptidyl-glutamine methylation(GO:0018364) |
| 0.1 |
0.4 |
GO:0045324 |
late endosome to vacuole transport(GO:0045324) |
| 0.1 |
1.6 |
GO:0000054 |
ribosomal subunit export from nucleus(GO:0000054) ribosome localization(GO:0033750) establishment of ribosome localization(GO:0033753) |
| 0.1 |
0.3 |
GO:1901857 |
positive regulation of cellular respiration(GO:1901857) |
| 0.1 |
5.6 |
GO:0045806 |
negative regulation of endocytosis(GO:0045806) |
| 0.1 |
0.3 |
GO:0007161 |
calcium-independent cell-matrix adhesion(GO:0007161) |
| 0.1 |
1.2 |
GO:0006003 |
fructose 2,6-bisphosphate metabolic process(GO:0006003) |
| 0.1 |
0.3 |
GO:0000707 |
meiotic DNA recombinase assembly(GO:0000707) |
| 0.1 |
0.4 |
GO:0097309 |
cap1 mRNA methylation(GO:0097309) |
| 0.1 |
0.6 |
GO:0048011 |
neurotrophin TRK receptor signaling pathway(GO:0048011) |
| 0.1 |
0.6 |
GO:0015015 |
heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
| 0.1 |
0.3 |
GO:0007056 |
spindle assembly involved in female meiosis(GO:0007056) |
| 0.1 |
0.4 |
GO:0071918 |
urea transmembrane transport(GO:0071918) |
| 0.1 |
1.6 |
GO:0007530 |
sex determination(GO:0007530) |
| 0.1 |
1.2 |
GO:0006362 |
transcription elongation from RNA polymerase I promoter(GO:0006362) |
| 0.1 |
0.9 |
GO:1904321 |
response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
| 0.1 |
0.1 |
GO:0071492 |
cellular response to UV-A(GO:0071492) |
| 0.1 |
0.1 |
GO:0016128 |
phytosteroid metabolic process(GO:0016128) phytosteroid biosynthetic process(GO:0016129) |
| 0.1 |
5.7 |
GO:0006890 |
retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
| 0.1 |
2.7 |
GO:0048013 |
ephrin receptor signaling pathway(GO:0048013) |
| 0.1 |
0.3 |
GO:0032332 |
positive regulation of chondrocyte differentiation(GO:0032332) |
| 0.1 |
0.3 |
GO:0003214 |
cardiac left ventricle morphogenesis(GO:0003214) |
| 0.1 |
0.4 |
GO:0006269 |
DNA replication, synthesis of RNA primer(GO:0006269) |
| 0.1 |
1.3 |
GO:2000279 |
negative regulation of DNA biosynthetic process(GO:2000279) |
| 0.1 |
0.3 |
GO:1902969 |
mitotic DNA replication(GO:1902969) |
| 0.1 |
0.4 |
GO:0070166 |
enamel mineralization(GO:0070166) |
| 0.1 |
0.1 |
GO:0060632 |
regulation of microtubule-based movement(GO:0060632) |
| 0.1 |
0.1 |
GO:0002322 |
B cell proliferation involved in immune response(GO:0002322) |
| 0.1 |
0.7 |
GO:0048147 |
negative regulation of fibroblast proliferation(GO:0048147) |
| 0.1 |
2.5 |
GO:2000785 |
regulation of autophagosome assembly(GO:2000785) |
| 0.1 |
0.3 |
GO:0008612 |
peptidyl-lysine modification to peptidyl-hypusine(GO:0008612) |
| 0.1 |
0.1 |
GO:0071286 |
cellular response to magnesium ion(GO:0071286) |
| 0.1 |
0.8 |
GO:0031507 |
heterochromatin assembly(GO:0031507) |
| 0.1 |
0.6 |
GO:0019509 |
L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
| 0.1 |
0.3 |
GO:0007100 |
mitotic centrosome separation(GO:0007100) |
| 0.1 |
0.1 |
GO:0000727 |
double-strand break repair via break-induced replication(GO:0000727) |
| 0.1 |
0.3 |
GO:0051969 |
regulation of transmission of nerve impulse(GO:0051969) |
| 0.1 |
1.7 |
GO:1904377 |
positive regulation of protein localization to cell periphery(GO:1904377) |
| 0.1 |
0.1 |
GO:0072498 |
embryonic skeletal joint development(GO:0072498) |
| 0.1 |
0.1 |
GO:0060290 |
transdifferentiation(GO:0060290) |
| 0.1 |
0.4 |
GO:0006438 |
valyl-tRNA aminoacylation(GO:0006438) |
| 0.1 |
0.4 |
GO:0019236 |
response to pheromone(GO:0019236) |
| 0.1 |
1.0 |
GO:0008063 |
Toll signaling pathway(GO:0008063) |
| 0.1 |
1.8 |
GO:0009303 |
rRNA transcription(GO:0009303) |
| 0.1 |
1.0 |
GO:0021521 |
ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
| 0.1 |
0.1 |
GO:0072488 |
ammonium transmembrane transport(GO:0072488) |
| 0.1 |
0.3 |
GO:0010815 |
bradykinin catabolic process(GO:0010815) |
| 0.1 |
0.1 |
GO:0070344 |
fat cell proliferation(GO:0070341) regulation of fat cell proliferation(GO:0070344) |
| 0.1 |
0.3 |
GO:0097500 |
receptor localization to nonmotile primary cilium(GO:0097500) |
| 0.1 |
1.8 |
GO:0031573 |
intra-S DNA damage checkpoint(GO:0031573) |
| 0.1 |
0.1 |
GO:0051639 |
actin filament network formation(GO:0051639) |
| 0.1 |
0.5 |
GO:1901301 |
regulation of cargo loading into COPII-coated vesicle(GO:1901301) |
| 0.1 |
0.3 |
GO:0010884 |
positive regulation of lipid storage(GO:0010884) |
| 0.1 |
1.3 |
GO:0051974 |
negative regulation of telomerase activity(GO:0051974) |
| 0.1 |
0.3 |
GO:0010940 |
positive regulation of necrotic cell death(GO:0010940) |
| 0.1 |
0.1 |
GO:0002175 |
protein localization to paranode region of axon(GO:0002175) |
| 0.1 |
0.1 |
GO:0000491 |
small nucleolar ribonucleoprotein complex assembly(GO:0000491) |
| 0.1 |
0.9 |
GO:0014820 |
tonic smooth muscle contraction(GO:0014820) artery smooth muscle contraction(GO:0014824) |
| 0.1 |
0.8 |
GO:0023021 |
termination of signal transduction(GO:0023021) |
| 0.1 |
0.4 |
GO:0042866 |
pyruvate biosynthetic process(GO:0042866) |
| 0.1 |
0.7 |
GO:1900119 |
positive regulation of execution phase of apoptosis(GO:1900119) |
| 0.1 |
2.3 |
GO:1902751 |
positive regulation of cell cycle G2/M phase transition(GO:1902751) |
| 0.1 |
2.0 |
GO:1902230 |
negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902230) |
| 0.1 |
0.3 |
GO:0061622 |
glycolytic process through glucose-1-phosphate(GO:0061622) |
| 0.1 |
0.4 |
GO:2000858 |
mineralocorticoid secretion(GO:0035931) aldosterone secretion(GO:0035932) regulation of mineralocorticoid secretion(GO:2000855) positive regulation of mineralocorticoid secretion(GO:2000857) regulation of aldosterone secretion(GO:2000858) positive regulation of aldosterone secretion(GO:2000860) |
| 0.1 |
0.1 |
GO:2000015 |
regulation of determination of dorsal identity(GO:2000015) |
| 0.1 |
0.3 |
GO:0007158 |
neuron cell-cell adhesion(GO:0007158) |
| 0.1 |
1.7 |
GO:1902042 |
negative regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902042) |
| 0.1 |
0.7 |
GO:0060330 |
regulation of response to interferon-gamma(GO:0060330) |
| 0.1 |
0.4 |
GO:0010749 |
regulation of nitric oxide mediated signal transduction(GO:0010749) |
| 0.1 |
1.0 |
GO:0006614 |
SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
| 0.1 |
0.3 |
GO:0071963 |
establishment or maintenance of cell polarity regulating cell shape(GO:0071963) |
| 0.1 |
0.4 |
GO:0006667 |
sphinganine metabolic process(GO:0006667) |
| 0.1 |
5.2 |
GO:0032543 |
mitochondrial translation(GO:0032543) |
| 0.1 |
0.3 |
GO:1903265 |
positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
| 0.1 |
1.7 |
GO:0032486 |
Rap protein signal transduction(GO:0032486) |
| 0.1 |
2.3 |
GO:0043968 |
histone H2A acetylation(GO:0043968) |
| 0.1 |
1.0 |
GO:0006346 |
methylation-dependent chromatin silencing(GO:0006346) |
| 0.1 |
0.8 |
GO:0060539 |
diaphragm development(GO:0060539) |
| 0.1 |
0.1 |
GO:0001821 |
histamine secretion(GO:0001821) |
| 0.1 |
0.4 |
GO:0036233 |
glycine import(GO:0036233) |
| 0.1 |
1.5 |
GO:0070208 |
protein heterotrimerization(GO:0070208) |
| 0.1 |
1.4 |
GO:0018230 |
peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
| 0.1 |
0.4 |
GO:0014912 |
negative regulation of smooth muscle cell migration(GO:0014912) |
| 0.1 |
0.3 |
GO:0007182 |
common-partner SMAD protein phosphorylation(GO:0007182) |
| 0.1 |
0.1 |
GO:0032792 |
negative regulation of CREB transcription factor activity(GO:0032792) |
| 0.1 |
0.4 |
GO:0052428 |
modulation of molecular function in other organism(GO:0044359) negative regulation of molecular function in other organism(GO:0044362) negative regulation of molecular function in other organism involved in symbiotic interaction(GO:0052204) modulation of molecular function in other organism involved in symbiotic interaction(GO:0052205) negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
| 0.1 |
0.1 |
GO:0033260 |
nuclear DNA replication(GO:0033260) |
| 0.1 |
0.5 |
GO:0031145 |
anaphase-promoting complex-dependent catabolic process(GO:0031145) |
| 0.1 |
1.5 |
GO:0031115 |
negative regulation of microtubule polymerization(GO:0031115) |
| 0.1 |
0.1 |
GO:0030579 |
ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
| 0.1 |
1.2 |
GO:0008299 |
isoprenoid biosynthetic process(GO:0008299) |
| 0.1 |
2.4 |
GO:0006607 |
NLS-bearing protein import into nucleus(GO:0006607) |
| 0.1 |
0.7 |
GO:0006363 |
termination of RNA polymerase I transcription(GO:0006363) |
| 0.1 |
1.5 |
GO:0044319 |
wound healing, spreading of cells(GO:0044319) epiboly involved in wound healing(GO:0090505) |
| 0.1 |
0.9 |
GO:0006729 |
tetrahydrobiopterin biosynthetic process(GO:0006729) tetrahydrobiopterin metabolic process(GO:0046146) |
| 0.1 |
0.4 |
GO:0045945 |
positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
| 0.1 |
0.4 |
GO:0035162 |
embryonic hemopoiesis(GO:0035162) |
| 0.1 |
3.6 |
GO:0042273 |
ribosomal large subunit biogenesis(GO:0042273) |
| 0.1 |
0.2 |
GO:2000659 |
regulation of interleukin-1-mediated signaling pathway(GO:2000659) |
| 0.1 |
0.2 |
GO:0019400 |
glycerol metabolic process(GO:0006071) alditol metabolic process(GO:0019400) |
| 0.1 |
0.4 |
GO:0016240 |
autophagosome docking(GO:0016240) |
| 0.1 |
0.4 |
GO:0060012 |
synaptic transmission, glycinergic(GO:0060012) |
| 0.1 |
0.2 |
GO:0007406 |
negative regulation of neuroblast proliferation(GO:0007406) |
| 0.1 |
0.2 |
GO:0050747 |
positive regulation of lipoprotein metabolic process(GO:0050747) |
| 0.1 |
0.6 |
GO:0034498 |
early endosome to Golgi transport(GO:0034498) |
| 0.1 |
0.7 |
GO:0006884 |
cell volume homeostasis(GO:0006884) |
| 0.1 |
0.4 |
GO:0050915 |
sensory perception of sour taste(GO:0050915) |
| 0.1 |
0.1 |
GO:0030578 |
PML body organization(GO:0030578) |
| 0.1 |
0.6 |
GO:2000270 |
negative regulation of fibroblast apoptotic process(GO:2000270) |
| 0.1 |
0.2 |
GO:0046370 |
fructose biosynthetic process(GO:0046370) |
| 0.1 |
0.9 |
GO:0048745 |
smooth muscle tissue development(GO:0048745) |
| 0.1 |
0.7 |
GO:0009226 |
nucleotide-sugar biosynthetic process(GO:0009226) |
| 0.1 |
0.2 |
GO:0009957 |
epidermal cell fate specification(GO:0009957) |
| 0.1 |
0.3 |
GO:0072643 |
interferon-gamma secretion(GO:0072643) |
| 0.1 |
1.3 |
GO:0019368 |
fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
| 0.1 |
1.0 |
GO:0030431 |
sleep(GO:0030431) |
| 0.1 |
2.5 |
GO:0016601 |
Rac protein signal transduction(GO:0016601) |
| 0.1 |
0.2 |
GO:0048239 |
negative regulation of DNA recombination at telomere(GO:0048239) regulation of DNA recombination at telomere(GO:0072695) |
| 0.1 |
0.6 |
GO:0021993 |
initiation of neural tube closure(GO:0021993) |
| 0.1 |
0.2 |
GO:0018149 |
peptide cross-linking(GO:0018149) |
| 0.1 |
4.6 |
GO:0051865 |
protein autoubiquitination(GO:0051865) |
| 0.1 |
0.7 |
GO:0044375 |
regulation of peroxisome size(GO:0044375) |
| 0.1 |
1.5 |
GO:0030811 |
regulation of nucleotide catabolic process(GO:0030811) |
| 0.1 |
1.1 |
GO:0018206 |
peptidyl-methionine modification(GO:0018206) |
| 0.1 |
0.1 |
GO:0060742 |
epithelial cell differentiation involved in prostate gland development(GO:0060742) |
| 0.1 |
1.3 |
GO:0031340 |
positive regulation of vesicle fusion(GO:0031340) |
| 0.1 |
0.2 |
GO:0009838 |
abscission(GO:0009838) |
| 0.1 |
0.5 |
GO:1903232 |
melanosome assembly(GO:1903232) |
| 0.1 |
1.0 |
GO:0035428 |
hexose transmembrane transport(GO:0035428) |
| 0.1 |
0.1 |
GO:1904861 |
excitatory synapse assembly(GO:1904861) |
| 0.1 |
0.9 |
GO:0043508 |
negative regulation of JUN kinase activity(GO:0043508) |
| 0.1 |
0.3 |
GO:0046391 |
5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
| 0.1 |
0.7 |
GO:0009262 |
deoxyribonucleotide metabolic process(GO:0009262) |
| 0.1 |
0.1 |
GO:1903215 |
negative regulation of protein targeting to mitochondrion(GO:1903215) |
| 0.1 |
0.7 |
GO:0010831 |
positive regulation of myotube differentiation(GO:0010831) |
| 0.1 |
1.1 |
GO:0044342 |
type B pancreatic cell proliferation(GO:0044342) |
| 0.1 |
0.2 |
GO:0003406 |
retinal pigment epithelium development(GO:0003406) |
| 0.1 |
0.3 |
GO:0045003 |
DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
| 0.1 |
0.5 |
GO:0046600 |
negative regulation of centriole replication(GO:0046600) |
| 0.1 |
0.2 |
GO:0060161 |
positive regulation of dopamine receptor signaling pathway(GO:0060161) |
| 0.1 |
0.3 |
GO:0060715 |
syncytiotrophoblast cell differentiation involved in labyrinthine layer development(GO:0060715) |
| 0.1 |
0.4 |
GO:0034214 |
protein hexamerization(GO:0034214) |
| 0.1 |
1.9 |
GO:0070534 |
protein K63-linked ubiquitination(GO:0070534) |
| 0.1 |
0.6 |
GO:0090503 |
RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
| 0.1 |
2.0 |
GO:1902857 |
positive regulation of nonmotile primary cilium assembly(GO:1902857) |
| 0.1 |
0.3 |
GO:0045793 |
positive regulation of cell size(GO:0045793) |
| 0.1 |
0.2 |
GO:0035696 |
monocyte extravasation(GO:0035696) regulation of monocyte extravasation(GO:2000437) |
| 0.1 |
0.3 |
GO:0070314 |
G1 to G0 transition(GO:0070314) |
| 0.1 |
0.2 |
GO:0030647 |
polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
| 0.1 |
0.2 |
GO:0044346 |
fibroblast apoptotic process(GO:0044346) regulation of fibroblast apoptotic process(GO:2000269) |
| 0.1 |
0.1 |
GO:2001274 |
negative regulation of glucose import in response to insulin stimulus(GO:2001274) |
| 0.1 |
0.8 |
GO:0030206 |
chondroitin sulfate biosynthetic process(GO:0030206) |
| 0.1 |
0.4 |
GO:1901164 |
negative regulation of trophoblast cell migration(GO:1901164) |
| 0.1 |
0.5 |
GO:0003085 |
negative regulation of systemic arterial blood pressure(GO:0003085) |
| 0.1 |
0.2 |
GO:0006527 |
arginine catabolic process(GO:0006527) |
| 0.1 |
4.1 |
GO:0045333 |
cellular respiration(GO:0045333) |
| 0.1 |
0.3 |
GO:0010826 |
negative regulation of centrosome duplication(GO:0010826) negative regulation of centrosome cycle(GO:0046606) |
| 0.1 |
0.3 |
GO:0003345 |
proepicardium cell migration involved in pericardium morphogenesis(GO:0003345) |
| 0.1 |
1.0 |
GO:0042347 |
negative regulation of NF-kappaB import into nucleus(GO:0042347) |
| 0.1 |
0.3 |
GO:1904152 |
regulation of retrograde protein transport, ER to cytosol(GO:1904152) |
| 0.1 |
0.8 |
GO:0050650 |
chondroitin sulfate proteoglycan biosynthetic process(GO:0050650) |
| 0.1 |
0.5 |
GO:0031579 |
membrane raft organization(GO:0031579) |
| 0.1 |
0.6 |
GO:0048820 |
hair follicle maturation(GO:0048820) |
| 0.1 |
0.2 |
GO:0006702 |
androgen biosynthetic process(GO:0006702) |
| 0.1 |
5.7 |
GO:0006888 |
ER to Golgi vesicle-mediated transport(GO:0006888) |
| 0.1 |
0.2 |
GO:0050748 |
negative regulation of lipoprotein metabolic process(GO:0050748) |
| 0.1 |
0.4 |
GO:0048861 |
leukemia inhibitory factor signaling pathway(GO:0048861) |
| 0.1 |
0.1 |
GO:0035871 |
protein K11-linked deubiquitination(GO:0035871) |
| 0.1 |
2.1 |
GO:0015804 |
neutral amino acid transport(GO:0015804) |
| 0.1 |
0.9 |
GO:0001912 |
positive regulation of leukocyte mediated cytotoxicity(GO:0001912) |
| 0.1 |
1.7 |
GO:0021680 |
cerebellar Purkinje cell layer development(GO:0021680) |
| 0.1 |
0.1 |
GO:0009214 |
cyclic nucleotide catabolic process(GO:0009214) |
| 0.1 |
0.1 |
GO:0017004 |
cytochrome complex assembly(GO:0017004) |
| 0.1 |
0.1 |
GO:0030212 |
hyaluronan metabolic process(GO:0030212) |
| 0.1 |
0.6 |
GO:0098964 |
dendritic transport of ribonucleoprotein complex(GO:0098961) dendritic transport of messenger ribonucleoprotein complex(GO:0098963) anterograde dendritic transport of messenger ribonucleoprotein complex(GO:0098964) |
| 0.1 |
0.6 |
GO:0006488 |
dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
| 0.1 |
0.9 |
GO:0033866 |
nucleoside bisphosphate biosynthetic process(GO:0033866) ribonucleoside bisphosphate biosynthetic process(GO:0034030) purine nucleoside bisphosphate biosynthetic process(GO:0034033) |
| 0.1 |
1.3 |
GO:0070207 |
protein homotrimerization(GO:0070207) |
| 0.1 |
0.1 |
GO:0051661 |
maintenance of centrosome location(GO:0051661) |
| 0.1 |
0.4 |
GO:1901386 |
negative regulation of voltage-gated calcium channel activity(GO:1901386) |
| 0.1 |
0.3 |
GO:0002082 |
regulation of oxidative phosphorylation(GO:0002082) |
| 0.1 |
1.2 |
GO:0002097 |
tRNA wobble base modification(GO:0002097) |
| 0.1 |
1.2 |
GO:0045292 |
mRNA cis splicing, via spliceosome(GO:0045292) |
| 0.1 |
0.1 |
GO:0002691 |
regulation of cellular extravasation(GO:0002691) |
| 0.1 |
0.5 |
GO:0048227 |
plasma membrane to endosome transport(GO:0048227) |
| 0.1 |
0.4 |
GO:0071883 |
activation of MAPK activity by adrenergic receptor signaling pathway(GO:0071883) |
| 0.1 |
0.6 |
GO:0050873 |
brown fat cell differentiation(GO:0050873) |
| 0.1 |
0.1 |
GO:0044803 |
multi-organism membrane organization(GO:0044803) |
| 0.1 |
1.7 |
GO:0000154 |
rRNA modification(GO:0000154) |
| 0.1 |
0.3 |
GO:0001887 |
selenium compound metabolic process(GO:0001887) selenocysteine metabolic process(GO:0016259) |
| 0.1 |
0.1 |
GO:0046292 |
formaldehyde metabolic process(GO:0046292) |
| 0.1 |
0.4 |
GO:0018202 |
peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) peptidyl-histidine modification(GO:0018202) |
| 0.1 |
0.1 |
GO:0033158 |
regulation of protein import into nucleus, translocation(GO:0033158) |
| 0.1 |
0.1 |
GO:0007442 |
hindgut morphogenesis(GO:0007442) |
| 0.1 |
0.1 |
GO:0046501 |
protoporphyrinogen IX metabolic process(GO:0046501) |
| 0.1 |
0.3 |
GO:0016598 |
protein arginylation(GO:0016598) |
| 0.1 |
1.1 |
GO:0046498 |
S-adenosylhomocysteine metabolic process(GO:0046498) |
| 0.1 |
0.4 |
GO:0009642 |
response to light intensity(GO:0009642) |
| 0.1 |
0.1 |
GO:0038003 |
opioid receptor signaling pathway(GO:0038003) regulation of opioid receptor signaling pathway(GO:2000474) |
| 0.1 |
1.5 |
GO:0043039 |
tRNA aminoacylation(GO:0043039) |
| 0.1 |
0.1 |
GO:0035937 |
estrogen secretion(GO:0035937) estradiol secretion(GO:0035938) regulation of estrogen secretion(GO:2000861) regulation of estradiol secretion(GO:2000864) |
| 0.1 |
0.1 |
GO:0014809 |
regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion(GO:0014809) |
| 0.1 |
0.1 |
GO:0014016 |
neuroblast differentiation(GO:0014016) |
| 0.1 |
1.0 |
GO:0010867 |
positive regulation of triglyceride biosynthetic process(GO:0010867) |
| 0.1 |
0.5 |
GO:0045792 |
negative regulation of cell size(GO:0045792) |
| 0.1 |
0.7 |
GO:0005980 |
polysaccharide catabolic process(GO:0000272) glycogen catabolic process(GO:0005980) glucan catabolic process(GO:0009251) cellular polysaccharide catabolic process(GO:0044247) |
| 0.1 |
0.6 |
GO:1904217 |
regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) regulation of serine C-palmitoyltransferase activity(GO:1904220) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
| 0.1 |
0.3 |
GO:0060314 |
regulation of ryanodine-sensitive calcium-release channel activity(GO:0060314) |
| 0.1 |
0.3 |
GO:0032464 |
positive regulation of protein homooligomerization(GO:0032464) |
| 0.1 |
0.1 |
GO:0071921 |
establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
| 0.1 |
0.1 |
GO:0048341 |
paraxial mesoderm formation(GO:0048341) |
| 0.1 |
0.2 |
GO:0090086 |
negative regulation of protein deubiquitination(GO:0090086) |
| 0.1 |
2.0 |
GO:0050830 |
defense response to Gram-positive bacterium(GO:0050830) |
| 0.1 |
0.5 |
GO:0080009 |
mRNA methylation(GO:0080009) |
| 0.1 |
0.1 |
GO:0060174 |
limb bud formation(GO:0060174) |
| 0.1 |
0.3 |
GO:0006824 |
cobalt ion transport(GO:0006824) |
| 0.1 |
0.3 |
GO:0007175 |
negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
| 0.1 |
0.7 |
GO:0015074 |
DNA integration(GO:0015074) |
| 0.1 |
0.1 |
GO:0048715 |
negative regulation of oligodendrocyte differentiation(GO:0048715) |
| 0.1 |
0.3 |
GO:0060051 |
negative regulation of protein ADP-ribosylation(GO:0010836) negative regulation of protein glycosylation(GO:0060051) |
| 0.1 |
0.2 |
GO:0090666 |
scaRNA localization to Cajal body(GO:0090666) |
| 0.1 |
0.4 |
GO:1901029 |
negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
| 0.1 |
0.3 |
GO:0030974 |
thiamine pyrophosphate transport(GO:0030974) |
| 0.1 |
0.2 |
GO:0044130 |
negative regulation of growth of symbiont in host(GO:0044130) negative regulation of growth of symbiont involved in interaction with host(GO:0044146) |
| 0.1 |
0.1 |
GO:0071557 |
histone H3-K27 demethylation(GO:0071557) |
| 0.1 |
0.2 |
GO:1903533 |
regulation of protein targeting(GO:1903533) |
| 0.1 |
0.4 |
GO:0001938 |
positive regulation of endothelial cell proliferation(GO:0001938) |
| 0.1 |
0.2 |
GO:0006613 |
cotranslational protein targeting to membrane(GO:0006613) |
| 0.1 |
0.2 |
GO:0007625 |
grooming behavior(GO:0007625) |
| 0.1 |
0.2 |
GO:0016321 |
female meiosis chromosome segregation(GO:0016321) |
| 0.1 |
0.2 |
GO:0006556 |
S-adenosylmethionine biosynthetic process(GO:0006556) |
| 0.1 |
0.1 |
GO:0071873 |
response to norepinephrine(GO:0071873) |
| 0.1 |
0.2 |
GO:0035609 |
C-terminal protein deglutamylation(GO:0035609) |
| 0.1 |
0.2 |
GO:0007006 |
mitochondrial membrane organization(GO:0007006) |
| 0.1 |
0.2 |
GO:1902253 |
regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902253) |
| 0.1 |
0.1 |
GO:0033313 |
meiotic cell cycle checkpoint(GO:0033313) |
| 0.1 |
0.2 |
GO:0002940 |
tRNA N2-guanine methylation(GO:0002940) |
| 0.1 |
1.0 |
GO:0033539 |
fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
| 0.1 |
0.3 |
GO:0033299 |
secretion of lysosomal enzymes(GO:0033299) |
| 0.1 |
0.2 |
GO:2001045 |
negative regulation of integrin-mediated signaling pathway(GO:2001045) |
| 0.1 |
0.2 |
GO:0050857 |
positive regulation of antigen receptor-mediated signaling pathway(GO:0050857) |
| 0.1 |
0.3 |
GO:0060690 |
epithelial cell differentiation involved in salivary gland development(GO:0060690) |
| 0.1 |
0.2 |
GO:0007172 |
signal complex assembly(GO:0007172) |
| 0.1 |
1.1 |
GO:0033120 |
positive regulation of RNA splicing(GO:0033120) |
| 0.1 |
0.3 |
GO:0045648 |
positive regulation of erythrocyte differentiation(GO:0045648) |
| 0.1 |
0.3 |
GO:0001547 |
antral ovarian follicle growth(GO:0001547) ovarian cumulus expansion(GO:0001550) fused antrum stage(GO:0048165) |
| 0.1 |
0.1 |
GO:0006532 |
aspartate biosynthetic process(GO:0006532) |
| 0.1 |
0.4 |
GO:0006307 |
DNA dealkylation involved in DNA repair(GO:0006307) |
| 0.1 |
0.2 |
GO:0070050 |
neuron cellular homeostasis(GO:0070050) |
| 0.1 |
0.2 |
GO:2000618 |
regulation of histone H4-K16 acetylation(GO:2000618) |
| 0.1 |
0.1 |
GO:0006930 |
substrate-dependent cell migration, cell extension(GO:0006930) |
| 0.1 |
0.5 |
GO:2001241 |
positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
| 0.1 |
0.2 |
GO:0051316 |
attachment of spindle microtubules to kinetochore involved in meiotic chromosome segregation(GO:0051316) |
| 0.1 |
0.2 |
GO:0015865 |
purine nucleotide transport(GO:0015865) |
| 0.1 |
0.1 |
GO:0038171 |
cannabinoid signaling pathway(GO:0038171) |
| 0.1 |
0.4 |
GO:0010661 |
positive regulation of muscle cell apoptotic process(GO:0010661) |
| 0.1 |
4.0 |
GO:1903214 |
regulation of protein targeting to mitochondrion(GO:1903214) |
| 0.1 |
0.1 |
GO:0015889 |
cobalamin transport(GO:0015889) |
| 0.1 |
0.1 |
GO:1901727 |
positive regulation of deacetylase activity(GO:0090045) positive regulation of histone deacetylase activity(GO:1901727) |
| 0.1 |
0.4 |
GO:0051013 |
microtubule severing(GO:0051013) |
| 0.1 |
0.4 |
GO:0006353 |
DNA-templated transcription, termination(GO:0006353) |
| 0.1 |
0.5 |
GO:0060856 |
establishment of blood-brain barrier(GO:0060856) |
| 0.1 |
0.1 |
GO:0010835 |
regulation of protein ADP-ribosylation(GO:0010835) |
| 0.1 |
0.1 |
GO:0034331 |
cell junction maintenance(GO:0034331) |
| 0.1 |
0.5 |
GO:0006561 |
proline biosynthetic process(GO:0006561) |
| 0.1 |
0.7 |
GO:0071459 |
protein localization to chromosome, centromeric region(GO:0071459) |
| 0.1 |
0.4 |
GO:0042267 |
natural killer cell mediated immunity(GO:0002228) natural killer cell mediated cytotoxicity(GO:0042267) |
| 0.1 |
0.2 |
GO:0097186 |
amelogenesis(GO:0097186) |
| 0.1 |
2.8 |
GO:1904893 |
negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
| 0.1 |
0.1 |
GO:0046349 |
amino sugar biosynthetic process(GO:0046349) |
| 0.1 |
1.4 |
GO:0032781 |
positive regulation of ATPase activity(GO:0032781) |
| 0.1 |
0.4 |
GO:0035411 |
catenin import into nucleus(GO:0035411) |
| 0.1 |
0.7 |
GO:0030953 |
astral microtubule organization(GO:0030953) |
| 0.1 |
0.2 |
GO:0035987 |
endodermal cell differentiation(GO:0035987) |
| 0.1 |
0.1 |
GO:0060712 |
spongiotrophoblast layer development(GO:0060712) |
| 0.1 |
1.2 |
GO:0032091 |
negative regulation of protein binding(GO:0032091) |
| 0.1 |
0.2 |
GO:0042590 |
antigen processing and presentation of exogenous peptide antigen via MHC class I(GO:0042590) |
| 0.1 |
0.3 |
GO:0045723 |
positive regulation of fatty acid biosynthetic process(GO:0045723) |
| 0.1 |
0.3 |
GO:0050774 |
negative regulation of dendrite morphogenesis(GO:0050774) |
| 0.1 |
0.7 |
GO:0030322 |
stabilization of membrane potential(GO:0030322) |
| 0.1 |
1.3 |
GO:0007020 |
microtubule nucleation(GO:0007020) |
| 0.1 |
0.5 |
GO:0071346 |
cellular response to interferon-gamma(GO:0071346) |
| 0.1 |
0.3 |
GO:0045743 |
positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
| 0.1 |
0.5 |
GO:0006471 |
protein ADP-ribosylation(GO:0006471) |
| 0.1 |
0.3 |
GO:0006370 |
7-methylguanosine mRNA capping(GO:0006370) |
| 0.1 |
1.8 |
GO:0006414 |
translational elongation(GO:0006414) |
| 0.1 |
0.1 |
GO:1902177 |
positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902177) |
| 0.1 |
0.3 |
GO:0006682 |
galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
| 0.1 |
0.2 |
GO:0036265 |
RNA (guanine-N7)-methylation(GO:0036265) |
| 0.1 |
0.9 |
GO:0001522 |
pseudouridine synthesis(GO:0001522) |
| 0.1 |
0.2 |
GO:0021933 |
radial glia guided migration of cerebellar granule cell(GO:0021933) |
| 0.1 |
0.3 |
GO:1902259 |
regulation of delayed rectifier potassium channel activity(GO:1902259) |
| 0.1 |
0.2 |
GO:0030951 |
establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
| 0.1 |
0.1 |
GO:0006668 |
sphinganine-1-phosphate metabolic process(GO:0006668) |
| 0.1 |
0.1 |
GO:0032075 |
positive regulation of nuclease activity(GO:0032075) |
| 0.1 |
0.1 |
GO:0036092 |
phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
| 0.1 |
0.5 |
GO:0031087 |
deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
| 0.1 |
0.1 |
GO:1990743 |
protein sialylation(GO:1990743) |
| 0.1 |
0.1 |
GO:0021894 |
cerebral cortex GABAergic interneuron development(GO:0021894) |
| 0.1 |
0.1 |
GO:1902474 |
regulation of protein localization to synapse(GO:1902473) positive regulation of protein localization to synapse(GO:1902474) |
| 0.1 |
0.3 |
GO:0036151 |
phosphatidylcholine acyl-chain remodeling(GO:0036151) |
| 0.1 |
1.8 |
GO:0061077 |
chaperone-mediated protein folding(GO:0061077) |
| 0.1 |
0.4 |
GO:1903504 |
regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090266) regulation of mitotic spindle checkpoint(GO:1903504) |
| 0.1 |
0.1 |
GO:1903546 |
protein localization to photoreceptor outer segment(GO:1903546) |
| 0.1 |
0.9 |
GO:0008637 |
apoptotic mitochondrial changes(GO:0008637) |
| 0.1 |
0.4 |
GO:0050957 |
equilibrioception(GO:0050957) |
| 0.1 |
0.2 |
GO:1902036 |
regulation of hematopoietic stem cell differentiation(GO:1902036) |
| 0.1 |
3.9 |
GO:0006413 |
translational initiation(GO:0006413) |
| 0.1 |
0.5 |
GO:0035455 |
response to interferon-alpha(GO:0035455) |
| 0.1 |
0.8 |
GO:0034389 |
lipid particle organization(GO:0034389) |
| 0.1 |
0.8 |
GO:0006044 |
N-acetylglucosamine metabolic process(GO:0006044) |
| 0.1 |
0.1 |
GO:0001562 |
response to protozoan(GO:0001562) |
| 0.1 |
0.2 |
GO:0032927 |
positive regulation of activin receptor signaling pathway(GO:0032927) |
| 0.1 |
0.1 |
GO:0030223 |
neutrophil differentiation(GO:0030223) |
| 0.1 |
0.1 |
GO:0042753 |
positive regulation of circadian rhythm(GO:0042753) |
| 0.1 |
0.4 |
GO:0033148 |
positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
| 0.1 |
0.2 |
GO:0061179 |
negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
| 0.1 |
0.4 |
GO:0010452 |
histone H3-K36 methylation(GO:0010452) |
| 0.1 |
0.4 |
GO:0033683 |
nucleotide-excision repair, DNA incision(GO:0033683) |
| 0.1 |
0.1 |
GO:0021555 |
midbrain-hindbrain boundary morphogenesis(GO:0021555) |
| 0.1 |
0.3 |
GO:0032310 |
prostaglandin secretion(GO:0032310) |
| 0.1 |
0.3 |
GO:0060837 |
blood vessel endothelial cell differentiation(GO:0060837) |
| 0.1 |
0.1 |
GO:2000297 |
negative regulation of synapse maturation(GO:2000297) |
| 0.1 |
0.2 |
GO:0030388 |
fructose 1,6-bisphosphate metabolic process(GO:0030388) |
| 0.1 |
0.8 |
GO:0031638 |
zymogen activation(GO:0031638) |
| 0.1 |
0.4 |
GO:0015838 |
amino-acid betaine transport(GO:0015838) carnitine transport(GO:0015879) |
| 0.1 |
0.1 |
GO:0010447 |
response to acidic pH(GO:0010447) |
| 0.1 |
0.6 |
GO:0052548 |
regulation of endopeptidase activity(GO:0052548) |
| 0.1 |
0.4 |
GO:1901844 |
regulation of cell communication by electrical coupling involved in cardiac conduction(GO:1901844) |
| 0.1 |
0.2 |
GO:0098869 |
cellular oxidant detoxification(GO:0098869) cellular detoxification(GO:1990748) |
| 0.1 |
1.2 |
GO:0016578 |
histone deubiquitination(GO:0016578) |
| 0.1 |
0.1 |
GO:0006409 |
tRNA export from nucleus(GO:0006409) tRNA transport(GO:0051031) tRNA-containing ribonucleoprotein complex export from nucleus(GO:0071431) |
| 0.1 |
0.2 |
GO:0015886 |
heme transport(GO:0015886) |
| 0.1 |
0.2 |
GO:1902608 |
regulation of large conductance calcium-activated potassium channel activity(GO:1902606) positive regulation of large conductance calcium-activated potassium channel activity(GO:1902608) |
| 0.1 |
0.2 |
GO:0032506 |
cytokinetic process(GO:0032506) |
| 0.1 |
0.6 |
GO:0045747 |
positive regulation of Notch signaling pathway(GO:0045747) |
| 0.1 |
0.1 |
GO:2000642 |
negative regulation of early endosome to late endosome transport(GO:2000642) |
| 0.1 |
0.2 |
GO:0043496 |
regulation of protein homodimerization activity(GO:0043496) |
| 0.1 |
0.2 |
GO:0018243 |
protein O-linked glycosylation via threonine(GO:0018243) |
| 0.1 |
0.4 |
GO:0030490 |
maturation of SSU-rRNA(GO:0030490) |
| 0.1 |
0.3 |
GO:0021942 |
radial glia guided migration of Purkinje cell(GO:0021942) |
| 0.1 |
0.1 |
GO:0051798 |
positive regulation of hair follicle development(GO:0051798) |
| 0.0 |
0.7 |
GO:0035458 |
cellular response to interferon-beta(GO:0035458) |
| 0.0 |
0.8 |
GO:0034260 |
negative regulation of GTPase activity(GO:0034260) |
| 0.0 |
0.2 |
GO:0021542 |
dentate gyrus development(GO:0021542) |
| 0.0 |
0.3 |
GO:0050679 |
positive regulation of epithelial cell proliferation(GO:0050679) |
| 0.0 |
0.0 |
GO:1901894 |
regulation of calcium-transporting ATPase activity(GO:1901894) |
| 0.0 |
0.8 |
GO:0048268 |
clathrin coat assembly(GO:0048268) |
| 0.0 |
0.0 |
GO:0060830 |
ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
| 0.0 |
0.7 |
GO:1902806 |
regulation of cell cycle G1/S phase transition(GO:1902806) |
| 0.0 |
0.1 |
GO:0090070 |
positive regulation of ribosome biogenesis(GO:0090070) positive regulation of rRNA processing(GO:2000234) |
| 0.0 |
0.1 |
GO:0090646 |
mitochondrial RNA 3'-end processing(GO:0000965) mitochondrial tRNA processing(GO:0090646) |
| 0.0 |
0.1 |
GO:0031954 |
positive regulation of protein autophosphorylation(GO:0031954) |
| 0.0 |
1.7 |
GO:0045727 |
positive regulation of translation(GO:0045727) |
| 0.0 |
0.8 |
GO:0061245 |
establishment or maintenance of apical/basal cell polarity(GO:0035088) establishment or maintenance of bipolar cell polarity(GO:0061245) |
| 0.0 |
0.0 |
GO:0031017 |
exocrine pancreas development(GO:0031017) |
| 0.0 |
0.6 |
GO:0060716 |
labyrinthine layer blood vessel development(GO:0060716) |
| 0.0 |
0.5 |
GO:1904591 |
positive regulation of protein import(GO:1904591) |
| 0.0 |
0.2 |
GO:0002051 |
osteoblast fate commitment(GO:0002051) |
| 0.0 |
0.9 |
GO:0046677 |
response to antibiotic(GO:0046677) |
| 0.0 |
0.1 |
GO:0034058 |
endosomal vesicle fusion(GO:0034058) |
| 0.0 |
2.2 |
GO:0042254 |
ribosome biogenesis(GO:0042254) |
| 0.0 |
0.1 |
GO:0033865 |
nucleoside bisphosphate metabolic process(GO:0033865) ribonucleoside bisphosphate metabolic process(GO:0033875) purine nucleoside bisphosphate metabolic process(GO:0034032) |
| 0.0 |
0.5 |
GO:2000480 |
negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
| 0.0 |
0.0 |
GO:0006116 |
NADH oxidation(GO:0006116) |
| 0.0 |
0.2 |
GO:2001269 |
positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
| 0.0 |
0.1 |
GO:0001827 |
inner cell mass cell differentiation(GO:0001826) inner cell mass cell fate commitment(GO:0001827) |
| 0.0 |
0.1 |
GO:0051560 |
mitochondrial calcium ion homeostasis(GO:0051560) |
| 0.0 |
0.0 |
GO:0032785 |
negative regulation of DNA-templated transcription, elongation(GO:0032785) |
| 0.0 |
0.1 |
GO:0097494 |
regulation of vesicle size(GO:0097494) |
| 0.0 |
0.4 |
GO:0006767 |
water-soluble vitamin metabolic process(GO:0006767) |
| 0.0 |
0.1 |
GO:0032286 |
central nervous system myelin maintenance(GO:0032286) |
| 0.0 |
0.2 |
GO:1902897 |
regulation of postsynaptic density protein 95 clustering(GO:1902897) |
| 0.0 |
0.1 |
GO:0035774 |
positive regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0035774) |
| 0.0 |
0.1 |
GO:0035426 |
extracellular matrix-cell signaling(GO:0035426) |
| 0.0 |
1.3 |
GO:0006506 |
GPI anchor biosynthetic process(GO:0006506) |
| 0.0 |
0.3 |
GO:0031047 |
gene silencing by RNA(GO:0031047) |
| 0.0 |
0.0 |
GO:0051204 |
protein insertion into mitochondrial membrane(GO:0051204) |
| 0.0 |
0.1 |
GO:0090315 |
negative regulation of protein targeting to membrane(GO:0090315) |
| 0.0 |
0.1 |
GO:0071168 |
protein localization to chromatin(GO:0071168) |
| 0.0 |
1.0 |
GO:0006626 |
protein targeting to mitochondrion(GO:0006626) |
| 0.0 |
0.2 |
GO:0043482 |
pigment accumulation(GO:0043476) cellular pigment accumulation(GO:0043482) |
| 0.0 |
0.2 |
GO:0034312 |
diol biosynthetic process(GO:0034312) |
| 0.0 |
0.0 |
GO:0008593 |
regulation of Notch signaling pathway(GO:0008593) |
| 0.0 |
0.2 |
GO:1990564 |
protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
| 0.0 |
0.0 |
GO:0002606 |
dendritic cell antigen processing and presentation(GO:0002468) positive regulation of antigen processing and presentation(GO:0002579) regulation of dendritic cell antigen processing and presentation(GO:0002604) positive regulation of dendritic cell antigen processing and presentation(GO:0002606) |
| 0.0 |
0.0 |
GO:0046007 |
negative regulation of activated T cell proliferation(GO:0046007) |
| 0.0 |
0.0 |
GO:0045351 |
type I interferon biosynthetic process(GO:0045351) |
| 0.0 |
0.0 |
GO:1901096 |
regulation of autophagosome maturation(GO:1901096) |
| 0.0 |
0.1 |
GO:0032096 |
negative regulation of response to food(GO:0032096) negative regulation of appetite(GO:0032099) |
| 0.0 |
0.1 |
GO:0042796 |
snRNA transcription from RNA polymerase III promoter(GO:0042796) |
| 0.0 |
0.5 |
GO:0040001 |
establishment of mitotic spindle localization(GO:0040001) |
| 0.0 |
0.1 |
GO:1990839 |
response to endothelin(GO:1990839) |
| 0.0 |
0.3 |
GO:0000188 |
inactivation of MAPK activity(GO:0000188) |
| 0.0 |
0.3 |
GO:0035773 |
insulin secretion involved in cellular response to glucose stimulus(GO:0035773) |
| 0.0 |
0.0 |
GO:0034497 |
protein localization to pre-autophagosomal structure(GO:0034497) |
| 0.0 |
0.4 |
GO:0021670 |
lateral ventricle development(GO:0021670) |
| 0.0 |
0.5 |
GO:0051457 |
maintenance of protein location in nucleus(GO:0051457) |
| 0.0 |
0.0 |
GO:0031627 |
telomeric loop formation(GO:0031627) |
| 0.0 |
0.3 |
GO:0018410 |
C-terminal protein amino acid modification(GO:0018410) |
| 0.0 |
0.0 |
GO:0070086 |
ubiquitin-dependent endocytosis(GO:0070086) |
| 0.0 |
0.1 |
GO:0010669 |
epithelial structure maintenance(GO:0010669) |
| 0.0 |
0.1 |
GO:1902524 |
positive regulation of protein K48-linked ubiquitination(GO:1902524) |
| 0.0 |
0.1 |
GO:0032625 |
interleukin-21 production(GO:0032625) interleukin-21 secretion(GO:0072619) |
| 0.0 |
0.3 |
GO:0071806 |
intracellular protein transmembrane transport(GO:0065002) protein transmembrane transport(GO:0071806) |
| 0.0 |
0.1 |
GO:0003215 |
cardiac right ventricle morphogenesis(GO:0003215) |
| 0.0 |
0.0 |
GO:0038180 |
nerve growth factor signaling pathway(GO:0038180) |
| 0.0 |
0.0 |
GO:0032471 |
negative regulation of endoplasmic reticulum calcium ion concentration(GO:0032471) |
| 0.0 |
0.3 |
GO:0015858 |
nucleoside transport(GO:0015858) |
| 0.0 |
0.0 |
GO:2000047 |
regulation of cell-cell adhesion mediated by cadherin(GO:2000047) |
| 0.0 |
0.1 |
GO:0042092 |
type 2 immune response(GO:0042092) |
| 0.0 |
0.1 |
GO:0097475 |
motor neuron migration(GO:0097475) |
| 0.0 |
0.1 |
GO:0050965 |
detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
| 0.0 |
0.2 |
GO:0061615 |
glycolytic process through fructose-6-phosphate(GO:0061615) |
| 0.0 |
0.3 |
GO:1990126 |
retrograde transport, endosome to plasma membrane(GO:1990126) |
| 0.0 |
0.0 |
GO:0000963 |
mitochondrial RNA processing(GO:0000963) |
| 0.0 |
0.1 |
GO:0072718 |
response to cisplatin(GO:0072718) |
| 0.0 |
0.1 |
GO:1902373 |
negative regulation of mRNA catabolic process(GO:1902373) |
| 0.0 |
0.1 |
GO:0071670 |
smooth muscle cell chemotaxis(GO:0071670) |
| 0.0 |
0.1 |
GO:0070164 |
negative regulation of adiponectin secretion(GO:0070164) |
| 0.0 |
0.1 |
GO:0042401 |
amine biosynthetic process(GO:0009309) cellular biogenic amine biosynthetic process(GO:0042401) |
| 0.0 |
0.2 |
GO:0042178 |
xenobiotic catabolic process(GO:0042178) |
| 0.0 |
0.1 |
GO:0019585 |
uronic acid metabolic process(GO:0006063) glucuronate metabolic process(GO:0019585) cellular glucuronidation(GO:0052695) |
| 0.0 |
0.7 |
GO:0006195 |
purine nucleotide catabolic process(GO:0006195) |
| 0.0 |
0.1 |
GO:0070508 |
sterol import(GO:0035376) cholesterol import(GO:0070508) |
| 0.0 |
0.0 |
GO:0048386 |
positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
| 0.0 |
0.1 |
GO:0098877 |
neurotransmitter receptor transport to plasma membrane(GO:0098877) |
| 0.0 |
0.0 |
GO:0061511 |
centriole elongation(GO:0061511) |
| 0.0 |
0.1 |
GO:0002093 |
auditory receptor cell morphogenesis(GO:0002093) |
| 0.0 |
0.2 |
GO:0006661 |
phosphatidylinositol biosynthetic process(GO:0006661) |
| 0.0 |
0.1 |
GO:0002949 |
tRNA threonylcarbamoyladenosine modification(GO:0002949) |
| 0.0 |
0.0 |
GO:0032620 |
interleukin-17 production(GO:0032620) |
| 0.0 |
0.1 |
GO:0099590 |
neurotransmitter receptor internalization(GO:0099590) |
| 0.0 |
0.4 |
GO:0016180 |
snRNA processing(GO:0016180) |
| 0.0 |
0.2 |
GO:0007130 |
synaptonemal complex assembly(GO:0007130) |
| 0.0 |
0.4 |
GO:0000338 |
protein deneddylation(GO:0000338) |
| 0.0 |
0.2 |
GO:0002053 |
positive regulation of mesenchymal cell proliferation(GO:0002053) |
| 0.0 |
0.2 |
GO:0034508 |
centromere complex assembly(GO:0034508) |
| 0.0 |
0.2 |
GO:0048672 |
positive regulation of collateral sprouting(GO:0048672) |
| 0.0 |
0.1 |
GO:0008298 |
intracellular mRNA localization(GO:0008298) |
| 0.0 |
0.2 |
GO:0043486 |
histone exchange(GO:0043486) |
| 0.0 |
0.0 |
GO:0051835 |
positive regulation of synapse structural plasticity(GO:0051835) |
| 0.0 |
0.0 |
GO:0080184 |
response to stilbenoid(GO:0035634) response to phenylpropanoid(GO:0080184) |
| 0.0 |
0.3 |
GO:2001239 |
regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001239) |
| 0.0 |
0.1 |
GO:0006220 |
pyrimidine nucleotide metabolic process(GO:0006220) |
| 0.0 |
0.0 |
GO:0002756 |
MyD88-independent toll-like receptor signaling pathway(GO:0002756) |
| 0.0 |
0.1 |
GO:0036035 |
osteoclast development(GO:0036035) |
| 0.0 |
0.0 |
GO:0021678 |
third ventricle development(GO:0021678) |
| 0.0 |
0.1 |
GO:0048742 |
regulation of skeletal muscle fiber development(GO:0048742) |
| 0.0 |
0.1 |
GO:0006356 |
regulation of transcription from RNA polymerase I promoter(GO:0006356) |
| 0.0 |
0.9 |
GO:0032436 |
positive regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032436) |
| 0.0 |
0.4 |
GO:0043484 |
regulation of RNA splicing(GO:0043484) |
| 0.0 |
0.1 |
GO:0001580 |
detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) sensory perception of bitter taste(GO:0050913) |
| 0.0 |
0.1 |
GO:0045123 |
cellular extravasation(GO:0045123) |
| 0.0 |
0.0 |
GO:0060011 |
Sertoli cell proliferation(GO:0060011) |
| 0.0 |
0.0 |
GO:0006098 |
pentose-phosphate shunt(GO:0006098) |
| 0.0 |
0.0 |
GO:0018199 |
peptidyl-glutamine modification(GO:0018199) |
| 0.0 |
0.0 |
GO:0033210 |
leptin-mediated signaling pathway(GO:0033210) |
| 0.0 |
0.1 |
GO:0002891 |
positive regulation of B cell mediated immunity(GO:0002714) positive regulation of immunoglobulin mediated immune response(GO:0002891) |
| 0.0 |
0.1 |
GO:0051958 |
methotrexate transport(GO:0051958) reduced folate transmembrane transport(GO:0098838) |
| 0.0 |
0.1 |
GO:0046599 |
regulation of centriole replication(GO:0046599) |
| 0.0 |
0.2 |
GO:0032467 |
positive regulation of cytokinesis(GO:0032467) |
| 0.0 |
0.0 |
GO:0051905 |
establishment of pigment granule localization(GO:0051905) |
| 0.0 |
0.0 |
GO:0030970 |
retrograde protein transport, ER to cytosol(GO:0030970) |
| 0.0 |
0.6 |
GO:0030838 |
positive regulation of actin filament polymerization(GO:0030838) |
| 0.0 |
0.0 |
GO:0036388 |
pre-replicative complex assembly involved in nuclear cell cycle DNA replication(GO:0006267) pre-replicative complex assembly(GO:0036388) pre-replicative complex assembly involved in cell cycle DNA replication(GO:1902299) |
| 0.0 |
0.0 |
GO:0090205 |
positive regulation of cholesterol biosynthetic process(GO:0045542) positive regulation of cholesterol metabolic process(GO:0090205) |
| 0.0 |
0.2 |
GO:0060044 |
negative regulation of cardiac muscle cell proliferation(GO:0060044) |
| 0.0 |
0.0 |
GO:0006000 |
fructose metabolic process(GO:0006000) |
| 0.0 |
0.0 |
GO:2000651 |
positive regulation of sodium ion transmembrane transporter activity(GO:2000651) |
| 0.0 |
0.1 |
GO:0035520 |
monoubiquitinated protein deubiquitination(GO:0035520) |
| 0.0 |
0.0 |
GO:0016242 |
negative regulation of macroautophagy(GO:0016242) |
| 0.0 |
0.1 |
GO:1901162 |
serotonin biosynthetic process(GO:0042427) primary amino compound biosynthetic process(GO:1901162) |
| 0.0 |
0.0 |
GO:0071947 |
protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
| 0.0 |
0.0 |
GO:0046415 |
urate metabolic process(GO:0046415) |
| 0.0 |
0.1 |
GO:0035720 |
intraciliary anterograde transport(GO:0035720) |
| 0.0 |
0.0 |
GO:0072530 |
purine-containing compound transmembrane transport(GO:0072530) |
| 0.0 |
0.2 |
GO:0001895 |
retina homeostasis(GO:0001895) |
| 0.0 |
0.0 |
GO:0032465 |
regulation of cytokinesis(GO:0032465) |
